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Cardiovascular disease kills over 750,000 people in the United States and an 
estimated 17.3 million people worldwide each year. Atherosclerosis, the formation of 
lipid-rich plaques in the walls of blood vessels, is the primary driver of complications in 
cardiovascular disease. These plaques partially or totally occlude downstream blood flow, 
resulting in ischemia and in peripheral limbs can require amputation. Alternatively, they 
can develop a vulnerable ‘fibrous cap’ phenotype that is susceptible to rupture, leading to 
a massive thrombotic cascade that can cause stroke or myocardial infarction. Current 
treatments predominately focus on either physically opening the blood vessels (e.g. 
balloon catheters and stenting) or creating bypass grafts. These treatments, however, 
frequently need to be repeated, particularly if patients do not change their dietary and 
exercise protocols. Therefore, a new approach to treating atherosclerosis that targets the 
mechanisms that drive vessels towards a pathogenic phenotype could be extremely 
helpful for preventing disease. 
Endothelial cells line blood vessels and are the principle cells responsible for 
interactions between blood flow and the surrounding tissue. In addition to providing a 
barrier, they are capable of sensing the mechanical forces induced by the blood flow. This 
sensing mechanism is responsible for driving their phenotype between an 
 ix 
‘atheroprotective’ or ‘atheroprone’ state; specifically, steady laminar shear stress results 
in ‘healthy’ endothelial cells while low or oscillatory shear stresses induces an 
inflammatory phenotype. While research has been conducted to look at the effects of 
shear stress on endothelial cells, the initial sensing mechanism that drives these 
downstream pathways remains unclear. Here we investigate the heparan sulfate 
proteoglycan syndecan-1 as a potential upstream regulator of these changes. Using 
custom-built shear stress application devices, we show that endothelial cells lacking 
syndecan-1 have a reduced response to shear stress and a general increase in 
inflammatory state. In vivo studies in a knockout mouse model extend these results; 
syndecan-1 knockout mice have more pronounced inflammatory responses and an 
increase in leukocyte-binding proteins in low shear conditions. These findings illustrate 
syndecan-1 as a potential target for future therapeutics aimed at driving potentially 
vulnerable vasculature away from a pathogenic phenotype. 
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Chapter 1: Introduction 
 
1.1 MOTIVATION  
Cardiovascular disease is the number one cause of death worldwide with 17.3 
mortalities annually1. This is projected to rise as increasing adoption of a Western diet 
leads to rapidly increasing global risk factors for cardiovascular disease; the estimated 
annual worldwide death toll will be more than 23.6 million by 2030. Obesity has doubled 
since 1980 and is estimated to cause 3-4 million deaths annually2. While some risk 
factors, such as smoking, have decreased in recent years, these declines have not nearly 
alleviated the need to find better treatments in the near future. 
Cardiovascular death and complications are primarily the result of atherosclerosis, 
which involves the formation of lipid-rich plaques in the walls of blood vessels. 
Atherosclerosis can cause a wide range of pathological ailments. Peripheral vascular 
disease limits blood flow to the extremities and can cause ulcers and subsequent 
amputations3,4. Coronary artery disease causes occlusion of blood flow to the heart, 
resulting in heart attacks. While occlusion itself has dangerous consequences, plaques can 
further develop into so called ‘vulnerable plaques’ in which the border between lipid-rich 
plaque and lumen is only separated by a thin fibrous cap. When large forces are applied, 
these thin caps can rupture, evicting the contents of the plaque into the lumen resulting in 
a massive thrombotic response. This thrombus then travels downstream where it can 
cause instant occlusion of the coronary arteries or parts of the brain, resulting in a heart 
attack or stroke, respectively.  
Treatment for atherosclerosis can be pharmacological or interventionist in nature. 
Physicians may prescribe medications such as statins, fibrates, or aspirin to reduce risk 
factors such as LDL cholesterol, triglycerides, and blood clots, but these do not directly 
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target atherosclerotic plaques and frequently cannot counterbalance other many risk 
factors5-8. Surgical interventions are divided into bypass grafts and angioplasty. Bypass 
grafting involves harvesting vasculature from elsewhere in the body, typically either 
diverting the left internal mammary artery or harvesting a saphenous vein from the leg, 
and attaching it as a bypass for the occluded vessel. This results in blood flow through a 
new, unoccluded vessel; however, the procedure requires long hospitalization periods 
since surgery must be performed using a cardiopulmonary bypass. Furthermore, if the 
patient continues their current diet/lifestyle the new graft is susceptible to developing its 
own atherosclerotic plaques. In some studies, up to 50% of the patients that undergo 
bypass surgery have another major cardiac event within ten years9,10. Balloon angioplasty 
is another common treatment for atherosclerosis. It involves running a catheter though 
the vasculature to the occlusion site and then expanding a balloon to push away the 
plaque tissue. While installation of a stent can help keep the vessel open, these 
procedures frequently suffer from restenosis occluding the vessel over time. While 
current treatments can help alleviate immediate conditions, they all suffer from a lack of 
long term success; therefore, a new class of therapeutics is needed that targets the 
pathways that drive vascular tissue toward dysfunction in order to prevent plaque 
formation in the first place.  
Endothelial cells have long been known to be able to sense the shear stress from 
blood flow11. Specifically, high levels of laminar shear stress drive endothelial cells 
towards a healthy, robust phenotype, while low or oscillatory shear levels induce the 
endothelial cells down pro-inflammatory, pro-atherosclerotic pathways12-14. While a great 
deal of interesting research has been conducted on the endothelial response to shear, little 
is still known about the initial mechanisms that drive these changes. Recent research has 
looked at the glycocalyx, which is a thick layer of glycans and proteoglycans that covers 
the lumenal surface of the cell, as a prime target for containing these initial sensory 
mechanisms15-17. Pahakis et al. showed that by digesting the glycosaminoglycan chains 
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from the glycocalyx with heparinase they could reduce the shear-induced increase of 
eNOS18. We are interested in how syndecan-1, a single-transmembrane protein in the 
glycocalyx with extracellular attachment sites for heparan sulfate and chondroitin sulfate, 
is involved in the endothelial shear mechanotransduction response. Indeed, shortly after 
beginning our studies, Koo et al. showed that syndecan-1 was unique among glycocalyx 
core proteins to increase levels in laminar ‘atheroprotective’ flow and decrease levels in 
oscillatory ‘atheroprone’ flow19. We examined the effects of syndecan-1 directly using a 
syndecan-1 knockout model both in vitro and in vivo. We showed that the absence of 
syndecan-1 results in a reduced mechanotransductive response to shear and an overall 
proinflammatory state. Our in vitro findings were corroborated by an increased VCAM-1 
presence in syndecan-1 knockout aortae and in neointimal formation in response to a 
partial carotid ligation surgery in our knockout mice. These studies, which are the first 
comprehensive analysis of syndecan-1’s role as a mechanotransducer in endothelial cells, 
support the hypothesis that it is directly involved in driving endothelial cell phenotype 
and may be a potentially novel pathway for future cardiovascular therapeutics.  
1.2 DISSERTATION ROADMAP 
The motivation for this dissertation study and a formative outline are listed in 
Chapter 1. A brief background and description of prior work that led to this research are 
described in Chapter 2. In Chapter 3, the design, optimization, and construction of novel 
devices for application of shear stress to in vitro cell cultures is described. Chapter 4 
highlights how these devices were used to investigate the role of syndecan-1 in 
endothelial mechanotransduction by application of shear stress to wild-type (WT) and 
syndecan-1 knockout (S1KO) endothelial cells in culture. These effects are examined in 
an in vivo setting in Chapter 5, which looks at the role of syndecan-1 in both native and 
induced shear environments. Chapter 6 illustrates conclusions from this dissertation study 
and provides directions for future research endeavors on this subject.  
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Chapter 2: Background 
 
2.1 ATHEROSCLEROSIS 
Cardiovascular disease is currently the number one cause of mortality worldwide 
and is responsible for 17.3 million deaths annually. In the United States, nearly 40% of 
people over age 40 and nearly 70% of people over age 60 have some form of 
cardiovascular disease1. With the increasing prevalence of a Western diet and reduced 
physical activity worldwide, the exponential rise of cardiovascular disease globally is 
quickly reaching epidemic levels. By 2030, cardiovascular disease is estimated to be 
responsible for 23.6 million annual deaths globally. Even for those for whom mortality is 
not an immediate consequence, the reduction in quality of life can be profound. 
Peripheral vascular disease can result in amputations and gangrene due to ischemia and 
those who survive myocardial infarction and stroke frequently have a long list of 
downstream complications including risk of future events and decreased mental and 
physical performance20-22. Additionally, the direct and indirect costs of cardiovascular 
disease and stroke cost more than $320 billion each year from health expenditures and 
lost productivity1. Therefore, the early diagnosis and treatment of cardiovascular disease 
is of paramount concern to overall global health. 
Atherosclerosis is the primary cause of cardiovascular complications. It is the 
result of a long-term, chronic development of plaque formation in the blood vessels. 
Briefly, chronically inflamed tissue develops a ‘fatty streak’ that causes frequent and 
persistent extravasation of leukocytes23. Over time, a combination of smooth muscle cell 
stenosis and inflammatory perfusion result in wall thickening that begins to occlude 
blood flow. This occlusion results in ischemia downstream of the plaque. In peripheral 
vascular disease, this results in a lack of blood flow to the extremities that frequently 
necessitates surgical intervention and eventual amputation24. Coronary artery disease 
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occlusion restricts blood flow to the heart and results in myocardial infarction. 
Additionally, atherosclerosis progression frequently results in the formation of a thin-
fibrous cap separating the plaque from the lumen. These ‘vulnerable plaques’ are prone to 
rupture, which results in a massive thrombotic response that travels downstream and can 
be lodged and block blood flow25. This frequently results in heart attack or stroke and has 
a high incidence of mortality. 
Current treatments for cardiovascular disease traditionally fall into two fields: 
grafting and angioplasty. For coronary grafting, a blood vessel is harvested or diverted 
from elsewhere in the body, usually a mammary artery or saphenous vein, and sutured to 
bypass the occlusion. This method restores normal blood flow; however, the long-term 
success is limited. Nearly 50% of patients who receive grafts have another cardiac event 
due to plaque occlusion within ten years9,10. Open heart surgery itself also results in long 
post-surgical hospital stays due to the highly invasive nature and recovery from time on a 
cardiopulmonary bypass. Another alternative is balloon angioplasty, in which a catheter 
is led into the occluded vessel and inflated to physically push the occlusion outwards 
radially. Installation of stents, wire metal meshes, has helped in recent years to hold the 
vessel open; however, the endothelial denudation the procedure causes often results in 
excessive smooth muscle cell proliferation and reclosing of the vessel due to restenosis26. 
While newer drug-eluting stents can help mitigate this response by releasing anti-
proliferative small molecules, such as rapamycin, this seems to only delay the 
progression and may increase the risk of thrombosis27. 
Most therapies for cardiovascular disease are either surgical or are very broad 
targeting. Changes in diet and exercise are traditionally prescribed, but patient adherence 
is frequently poor. Common pharmaceuticals include statins, fibrates, and aspirin, which 
can help to lower risk factors, but these are frequently not sufficient to overcome disease5-
8. Therefore, it would be extremely useful to fully understand the mechanisms that lead to 
vascular pathology in order to develop a new generation of cardiovascular therapeutics. 
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2.2. ENDOTHELIAL SHEAR-MEDIATED MECHANOTRANSDUCTION 
 The current practice of clinical cardiovascular medicine lacks therapies that 
specifically combat the powerful effects of disturbed hemodynamics that underlie 
widespread diseases such as hypertension and atherosclerosis. Arterial 
mechanotransduction has been the subject of intense experimental and theoretical study 
over the past decades23,28. The search for potential mechanotransducers, molecules that 
serve as force sensors and activators of mechanical responses, has revealed a variety of 
complex and fascinating mechanisms through which hemodynamic forces can alter 
arterial biology29-33. In the artery, endothelial cells (ECs) line the lumen of the vessel and 
are exposed directly to shear forces from blood flow. Atherosclerotic plaques have long 
been known to preferentially localize to particular regions of the vasculature34. A fluid 
dynamical analysis of these atherosclerotic regions reveals that they coincide with the 
areas where the fluid flow is disturbed. In contrast to regions of healthy vasculature 
where blood flow imparts a regular, laminar shear stress on the endothelial cells lining 
the vessel, these susceptible regions impart a low, oscillatory shear stress on the vessel 
wall. It appears that the initial sensory mechanisms that drive vascular tissue down either 
a healthy or disease-driven pathway is in part mechanically mediated. 
 Since the initial discovery of endothelial shear-mediated mechanotransduction, 
there have been a multitude of studies investigating the pathways involved. Initial studies 
showed that exposing in vitro endothelial cells to fluid shear stress results in cell 
alignment with flow35. Other studies have found that laminar shear stress results in 
increased production of vasodilatory factors such as endothelial nitric oxide synthase 
(eNOS) and decreased production of many inflammatory cytokines36,37. Several key 
players in this process have been identified. Krüppel-like factor 2 (KLF2) was shown to 
drive many of these responses38,39. Integrins have long been thought to play a role in 
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endothelial mechanotransduction40. Additionally, Tzima et al. showed that platelet 
endothelial cell adhesion molecule-1 (PECAM-1), vascular endothelial cadherin (VE-
Cadherin), and vascular endothelial growth factor receptor-2 (VEGFR-2) form a complex 
between cell-cell junctions that drives many of the responses previously seen41. Both of 
these mechanisms, however, require transmittance of force from the lumenal surface 
either directly via the cell membrane or cytoskeleton or via currently unknown 
biochemical pathways. 
 Studies of endothelial mechanotransduction have also been conducted in vivo. 
Typically they fall into two categories: differing regions of native shear stress and those 
of induced shear stress. Native shear stress studies utilize a fluid mechanical analysis of 
fluid flow through the vasculature to identify regions that have differing wall shear 
stresses. These regions are frequently found on the inside walls of high angle curvature 
and after vessel bifurcations. Gelfand et al. showed that in the aorta, the lesser arch has 
higher nuclear localization levels of β-catenin42. Induced shear stress experiments use 
surgical techniques to alter the native shear stress characteristics and study how the 
vasculature remodels and responds to the change in shear stress. One method is the 
carotid cuff, in which a piece polyetherketone tubing is perivascularly applied to the 
carotid artery of a mouse and then tied off, restricting downstream blood flow43. This 
produces an increase in vascular cell adhesion molecule-1 (VCAM-1) and a decrease in 
eNOS production43,44. One shortcoming of the carotid cuff is any observed inflammatory 
response cannot be solely attributed to change in shear stress patterns because the cuff 
itself can cause some irritation. To overcome this, Nam et al. developed a partial carotid 
ligation model in which the external carotid, internal carotid, and occipital arteries are all 
ligated, allowing downstream flow only through the smaller superior thyroid artery45. 
This creates a robust region of low shear stress that also exhibits oscillatory flow 
characteristics common in atherosclerosis-prone regions of the vasculature. Using a 
plaque-susceptible ApoE knockout mouse model, they demonstrated profound plaque 
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formation and vessel remodeling in response to this change in shear stress. All of these 
studies, however, are focused downstream of the initial endothelial mechanotransduction 




 Recently the endothelial glycocalyx has become of potential target of interest for 
this initial endothelial mechanotransduction response. The glycocalyx is a relatively thick 
structure of glycans and proteoglycans that extends out from the luminal side of the 
endothelial cell. Proteoglycans contain one or more glycosaminoglycan (GAG) chains 
attached to a single core protein that is either transmembrane or bound via a 
glycosylphosphatidylinositol (GPI)-linker. These GAG chains typically have 90-95% 
carbohydrate content, interact with numerous growth factors and other signaling 
molecules, and are much larger than their core protein46. One class of proteoglycans, the 
heparan sulfate proteoglycans (HSPGs), has become an increasingly interesting target in 
recent years. These complex molecules consist of a protein core modified with heparan 
sulfate glycosaminoglycan chains and can interact directly with the forces produced by 
blood flow. These surface molecules extend beyond the surface of the endothelial cell by 
nearly three times the cell thickness47. On the molecular scale, this dwarfs the extension 
of other surface receptors and is clearly the first point of contact for blood flow applied to 
the cells. Consequently, these poorly understood molecules are likely among the first 
molecules to be affected by applied forces from blood flow. Due to their location on the 
cell surface and their interaction with cytoskeletal and adhesion-associated molecules, 
cell surface proteoglycans are ideally located to be one of the primary sensing 
components for stretch- and flow-induced cellular responses within arteries and to 
mediate endothelial interactions with circulating cells.  
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Previous studies have focused on using enzymatic digestion techniques to 
examine the endothelial response to shear stress with or without the various 
glycosaminoglycan chains. Using cultured cells, Florian et al. studied the production of 
nitric oxide (NO) in endothelial cells under shear stress48. They treated cells with an 
enzyme to digest heparan sulfate chains (heparinase) and then exposed the cells to 
various shear stress regimes. Heparan sulfate digestion led to a three-fold decrease in the 
NO production after exposure to steady shear stress as well as a four-fold decrease in the 
NO production following treatment with oscillatory shear stress. In addition, digestion 
with heparinase did not inhibit bradykinin-induced increases in NO production. Other 
studies on endothelial cells in culture also demonstrated that digestion with 
neuraminidase and hyaluronidase attenuated shear-induced NO release while digestion 
with chondroitinase did not49. Additionally, shear-induced increases in prostacyclin-2 
(PGI2) were not affected by removal of heparan sulfate, sialic acid, chondroitin sulfate or 
hyaluronan18. In vivo studies have also supported the involvement of proteoglycans in 
controlling shear stress-induced arterial vasodilation. Increases in blood flow cause 
arteries to dilate in an endothelium-dependent manner50,51. Several studies have supported 
the role of elements of the glycocalyx in the control of the shear-induced vasodilatory 
response of arteries. Hecker et al. examined the vasoconstriction of rabbit femoral 
arteries in ex vivo organ culture and found that incubation with neuraminidase, an enzyme 
that digests sialic acid moieties, reduced shear stress-induced NO release52. In contrast, 
neuraminidase digestion did not have an effect on acetylcholine-induced NO release. A 
recent study examined the effect of long-term shear stress on relative gene and protein 
production of different glycocalyx components; syndecan-1 was unique in that it had an 
increased production in the presence of laminar shear stress but decreased production 
during oscillatory, ‘atheroprone’ shear stress19. Therefore, syndecan-1 is a very 
interesting target for a proteoglycan that may govern the endothelial 




 Syndecan-1 is a member of the syndecan family of heparan sulfate proteoglycans. 
It is a 310 amino acid single transmembrane protein with serine residues attachment sites 
for three heparan sulfate and two chondroitin sulfate glycosaminoglycan chains53. It can 
be converted into a soluble form via proteolytic cleavage of its ectodomain; indeed, 
higher levels of soluble syndecan-1 in serum are found in several forms of inflammation 
and cancer54,55. Syndecan-1 is involved in synthesizing numerous biochemical pathways 
including functioning as a cofactor for growth factors56, activating αvβ3 and αvβ5 
integrins57, and linking to the actin cytoskeleton via the cytoplasmic tail58. 
 Some studies have shown syndecan-1 to be a potentially interesting regulator of 
endothelial mechanotransduction shear response. Götte et al. showed that syndecan-1 
knockout mice demonstrated an increase in leukocyte adhesion in the blood vessels in the 
retina59. Additionally, these mice have been shown to have a reduced glycocalyx 
thickness60. While these studies illustrate syndecan-1 as in interesting target, there has not 
yet been a detailed function analysis of the role of syndecan-1 in endothelial shear-
mediated mechanotransduction. Therefore, it is the purpose of this study to investigate 
the role both in vitro and in vivo using novel mechanical devices and surgical 
manipulation techniques. 
 
2.5. MOUSE MODELS 
 This study uses two different mouse models: C57BL/6J (wild-type [WT]) and 
syndecan-1 knockout (S1KO) mice from a C57BL/6J background. The WT mice are the 
most widely studied mouse model and have been prolifically used to create genetically-
modified mouse strains. They have also been used in a wide variety of research areas 
including cardiovascular biology.  The S1KO mice were a generous gift from Dr. Ram 
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Sasisekharan (Massachusetts Institute of Technology) and were created from, and 
recently backcrossed to, a C57BL/6J line. This combination of a robustly-studied base 
strain and global genetic knockout provides a powerful toolset to investigate the role of 




Chapter 3: Shear Stress Application Devices1 
 
3.1 INTRODUCTION 
The past decades of cardiovascular research have revealed a variety of shear 
stress-mediated processes that are powerful regulators of vascular homeostasis and 
disease progression61. These mechanical force-mediated mechanisms are integral in 
controlling a diverse set of pathophysiological processes including thrombosis, 
atherosclerosis and the response to arterial injury62. Fluid shear forces have direct effects 
on the endothelium and mediate circulating cell interactions63. In addition, shear forces 
can also have a direct mechanical effect on the vessel wall and can mediate the 
interactions of blood proteins and circulating cells with the luminal surface64. As shear 
forces have been found to be integral in regulating many aspects of vascular biology, a 
number of systems have been created to examine the effects of shear forces on cultured 
cells in a controlled manner65-71. 
Existing devices have utilized two broad categories of driving mechanisms for 
creating flow over cultured cells72. The first is the parallel-plate or channel 
configuration65-67. These systems consist of a culture chamber coated to allow cell culture 
on one or more of the surfaces. Fluid flow through the chamber is typically driven by 
either a syringe or peristaltic pump with an elevated reservoir to control pressure and 
create steady flow. Microfluidic platforms using this principle have also been adapted to 
serve to provide shear stress to cells in culture73-75. An alternative type of flow system 
involves the use of a low-angle cone that is rotated at a constant velocity over the cells69-
                                                
1 Some work contained in this chapter was previous published in the following journal article: Voyvodic, P. 
L., Min, D. & Baker, A. B. A multichannel dampened flow system for studies on shear stress-mediated 
mechanotransduction. Lab on a chip 12, 3322-3330, doi:10.1039/c2lc40526a (2012). The individual 
contributions by the authors are as follows: Peter L Voyvodic- Principle author and conductor of the 
research; Daniel Min- Undergraduate research assistant to PL Voyvodic; Aaron B Baker- Supervisor to PL 
Voyvodic. 
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71. This has the advantage of being able to create defined fluid stresses and has been used 
to create both steady flow and complex, time-varying flow profiles71.  
  
3.2  MULTI-THROUGHPUT SHEAR STRESS DEVICE 
We sought to create a flow system that is capable of creating steady flow in cells 
cultured in multichannel flow plates. This is a critical parameter for studies that aim to 
examine the interactiolns of multiple pathways or to understand systems-level behavior in 
mechanotransduction. Limitations of many of the current systems for creating fluid flow 
on cultured cells include the low throughput of the system and the length of experiments 
that can be performed. Understanding the chronic, long-term response to changes in fluid 
shear stress is critical to understanding the mechanisms that mediate chronic vascular 
diseases. Consequently, long term experiments on cellular adaptation to shear stresses are 
clearly of interest. In addition, shear stresses also mediate the interactions of the various 
cell types that are suspended in the blood flow. Thus, in vitro assays of cells in 
suspension interacting with adherent cell types are critical in studying the mechanisms of 
important pathophysiological processes including immune cell recruitment76, cancer cell 
metastasis77, and thrombosis78.  
Our aim was to create a system that could overcome the limitations of previous 
designs by allowing higher and expandable throughput with steady flow and a closed-
loop configuration to allow cells to be cultured indefinitely under flow in isolation from 
other flow channels. The system presented here consists of a multichannel peristaltic 
pump connected with a novel pulse dampening system to allow steady flow in a closed 
loop. We performed a detailed optimization of this pulse dampener to minimize volume 
and flow variation from pumping. Finally, we compared the cellular response to 
undamped, partially-damped, and fully-damped flow in terms of shear stress induced 




3.2.1 Materials and Methods 
3.2.1.1. Flow Loop Components and Pulsatility Measurements. 
A multichannel peristaltic pump (MCP Standard, Ismatec) with a 24 channel 
pump head was used to create flow in the system. The pumping heads were calibrated for 
average flow rates using pumped volume measurements to an accuracy of less than 
±0.5%. The recorded flow velocities were measured using an in-line ultrasonic 
flowsensor (Model ME3PXN; Transonic USA) connected to a flowmeter (TS410 Transit 
Time Flowmeter; Transonic USA) with an accuracy of ±4%. The output signal from the 
flow was processed using Powerlab 4/30 and LabChart Pro software (ADInstruments). 
Post-processing was performed with Matlab (Mathworks). Shear stress in the flow 
chambers at the cell culture surface was calculated based on the mean flow rate from the 






where 2h is the height of the channel, 2b is the width of the channel, η is viscosity, and ϕ 
is the flow rate through the channel79. 
3.2.1.2. Cell Culture and Immunocytochemical Staining.  
Human umbilical vein endothelial cells (HUVECs) were used between passages 4 
and 6. These cells were grown in MCDB-131 media with growth supplements (Lonza) 
with a total of 7.5% fetal bovine serum (FBS; Invitrogen). HUVECs were seeded into the 
flow chambers (µ-Slide VI0.4; ibidi, LLC) at 7x105 cells/mL and grown to confluence. 






















































37°C and 5% CO2. The cells were then washed with PBS and fixed in 4% 
paraformaldehyde for 20 min. The cells were then permeabilized in 0.1% Triton X-100 
and blocked with 5% FBS for 1 hour. Next, the cells were exposed to a 1:50 dilution of 
primary antibodies for paxillin and eNOS (Santa Cruz Biotechnology) in 1% bovine 
serum albumin (BSA) overnight at 4°C. The cells were then washed three times in 
PBS/1% BSA and treated with a 1:1000 dilution of fluorescently-labeled secondary 
antibodies for 1 hour at room temperature. The actin cytoskeleton was also labeled by 
treating the cells for 1 hour in a 1:500 solution of Alexa 594-labeled phalloidin 
(Invitrogen). Finally the cells were mounted in a 4',6-diamidino-2-phenylindole (DAPI)-
containing mounting medium and imaged using an epifluorescent microscope (Carl 
Zeiss). Morphometric analysis of the cells was performed using Metamorph software 
(Molecular Devices).  
3.2.1.3. Statistical Analysis.  
All results are shown as mean ± standard error of the mean. Comparisons between 
only two groups were performed using a 2-tailed Student’s t-test.  Differences were 
considered significant at p<0.05. Multiple comparisons between groups were analyzed by 
2-way ANOVA followed by a Tukey post-hoc test. A 2-tailed probability value <0.05 
was considered statistically significant. 
 
3.2.2. Results 
3.2.2.1. Characterization of baseline pulsation in the multichannel peristaltic pump. 
Peristaltic pumping works through the rhythmic constriction of flexible tubing to 
create a local pressure gradient that drives flow. This mode of pumping is advantageous 
in that it does not require flow-driving elements (impeller or similar components) to 
interact with the flow directly. We first characterized the temporal profiles of flow in the 
closed flow loop with a peristaltic pump. Baseline measurements of the fluid velocity are 
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shown in Figure 3.1. These demonstrate that the pump produced significant pulsation in 
a closed-loop system with the peristaltic pump. The magnitude of the variation (from 
minimum trough to maximum peak) was quantified and expressed as relative to the mean 
velocity (Figure 3.1). At all pumping speeds tested, the variation in velocity was greater 
than 100% of the mean flow.  
 
Figure 3.1. Baseline characterization of flow loop velocity profiles at different mean 
flow rates. (A) Experimental set-up including an in-line ultrasonic flow probe with an 
analog-to-digital converter and software recording program was used to measure flow 
within the loop. (B) The magnitude and form of the flow from the peristaltic pump varied 
with the mean flow rate. (C) Pulsation of the pump varied with mean flow velocity. 
Quantitative measurement of relative pulsation was calculated as a ratio of minimum to 
maximum flow to the overall mean flow rate. 
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3.2.2.2. Two dampening chambers are required to effectively limit flow pulsation in a 
closed flow loop. 
We designed a prototype system for a pulsation dampener that consisted of a 
simple chamber having inflow and outflow ports (Figure 3.2). We first incorporated this 
single pulse dampener into our system between the outflow of the peristaltic pump and 
the inlet of the parallel-plate flow channel. The pulsation dampening chamber was 
partially filled with culture media while it was open to the surrounding atmosphere. The 
lid was then closed to trap a volume of air within the system. This mode of initiating the 
system eliminated trapped bubbles and allowed us to adjust the ratio between air and 
culture media. The tubing in the non-pumping region of the system was gas permeable to 
allow for gas exchange.  
We found that a single pulse dampener in the outflow of the pump had little effect 
on the mean variation in flow (Figure 3.3). The single dampener essentially shifted the  
 
Figure 3.2. Prototype pulse dampener design with optimized parameters. The pulse 
dampener consists of an enclosed, fixed-volume chamber with an inlet and outlet. Inside, 
there is a variable liquid level with the rest of the volume taken up by trapped air. During 
the course of optimizing our system for pulsatility reduction, we focused on three 
parameters: 1) the total chamber volume, 2) the liquid to total volume ratio, and 3) the 
position of the inlet and outlet. 
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flow pulsation to a lower magnitude, lowering the maximum flow but maintaining the 
same mean flow variation. This effect is likely due to the closed-loop configuration of the 
system we were using. In a closed system, the input and output pressure for the peristaltic 
pump is a complex function of the type and mechanism of pumping80. We added a second 
pulse dampener at the output side of the parallel-plate flow chamber and the input side of 
the pump. The addition of the second pulse dampener dramatically decreased the mean 
flow variation. The effectiveness of the dual pulse dampener system increased with 
increasing mean velocity, correlating also with increased frequency of pulsation (Figure 
3.3).  
3.2.2.3. Effect of total volume on pulse dampening effectiveness. 
After demonstrating the need for a two pulse dampener system to reduce flow 
pulsation, we sought to further optimize other design parameters to maximize reduction 
of pulsation while minimizing the fluidic volume needed per flow loop. While a larger 
volume of fluid protects the cells from rapid changes in temperature, pH, and the buildup 
of metabolic products, a compromise is needed between these factors and the economic 
burden of high volumes of media. To test the effects of altering the total overall volume 
of the pulse dampener on damping the flow pulsations, we chose a fixed intermediate 
liquid volume to total volume ratio of 0.4 within the various chambers. Our experimental 
tests of chambers of differing total volume demonstrated a relation between mean 
velocity of pumping, chamber size, and the mean flow variation (Figure 3.4). Larger 
chambers reduced the amount of pulsatility but with diminishing returns as the chamber 
size increased. From the sizes tested we selected the total volume size of 15 mL as this 
captured the majority of the dampening effect while minimizing the media volume and 
maintaining an overall size that was compatible with culture incubators. 
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Figure 3.3. Two pulse dampening units are needed to reduce pulsatility from a 
peristaltic pump in a closed flow loop. Flow waveforms were recorded for the 
undamped system, with a single pulse dampener upstream of the flow probe, and with 
two pulse dampeners (one on each the inlet and outlet sides of the peristaltic pump). For 
these recordings, the inlet and outlet of the dampening chambers were placed at the 
middle and lower positions, respectively, and the liquid to volume ratio was set to 0.40. 
*Significantly different from the other two conditions (p<0.05). **The single-damped 
system is significantly different than the undamped system (p<0.05). 
3.2.2.4. Effect of liquid volume ratio on pulse dampening of flow system.  
We next investigated the effects of altering the liquid to total volume ratio within 
the pulse dampener chamber. The gas component in the dampener provides compliance 
through its compressibility while the liquid component provides compliance through 
changes in fluid height. We found that maximizing the air in the chamber (a liquid to 
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total volume ratio of 0.25) led to close to a 100% decrease in pulsation in comparison to a 
ratio of 0.85 (Figure 3.5).  
 
Figure 3.4. Increased pulse dampener volume reduces pulsation in a peristaltic, 
closed-loop system. Flow waveforms were recorded using pulse dampeners of varying 
total volumes. The inlets and outlets were placed at the middle and lower positions, 
respectively, and the liquid to total volume ratio was set to 0.40. Relative pulsation was 
calculated as the peak-to-peak measurement divided by the mean flow rate. 
*Significantly different values from the other three conditions (p <0.05). 
3.2.2.5. Inlet-to-outlet height had a limited effect on pulse dampening effectiveness. 
The transition between small diameter tubing and a larger chamber induces a 
small region of complex flow that introduces resistance. In addition, this transition 
creates a reflected wave similar to those formed in arterial systems at bifurcations81. Flow 
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within the chamber is complex and may contain circulation currents that depend on flow 
velocity. Flow circulation itself can be used as a means of pulse dampening and flow 
circulation pulse dampeners have been designed to work on large scale, industrial 
hydraulic systems82. To examine whether these effects altered the effectiveness of the 
pulse dampening system, we explored the effect of altering the ratio between the inlet and 
outlet height on the pulse dampener effectiveness. The rationale was that the positioning 
of the inlet and outlet may lead to changes in flow within the dampener. We found that at 
most of the mean flow velocities, the location of the inlet and outlet had only a weak 
effect on the damping that occurred. However, in the high flow case (20 mL/min), having 
the flow in a high-inlet/mid-outlet configuration caused a small decrease in damping 
capacity (Figure 3.6). This presumably was a consequence of the internal flow created 
within the chamber (having a greater effect as flow velocities increased). Due to its high 
damping capacity and compatibility with other optimized parameters, the mid-inlet/low-
outlet configuration was chosen. 
3.2.2.6. Alterations in fluid viscosity over the physiological range for blood had a 
minimal effect on pulse dampener effectiveness. 
While standard culture media is a common and simple way to create fluid shear 
over cells in culture, many groups have also explored using fluids that have a viscosity 
similar to blood83,84. In addition, studies on thrombosis have used blood in a flow system 
to examine the mechanisms of thrombosis85. We examined the ability of the flow system 
to dampen flow pulsation while varying the viscosity of the flowing liquid to match that 
of culture media, blood and twice the value of blood viscosity. Over this range of 
viscosities there was little change in the overall pulse dampening (Figure 3.7).  
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Figure 3.5. Effect of liquid ratio within the pulse dampener on variations in fluid 
flow. Liquid ratio reduces dampening capacity at high values. Flow waveforms were 
recorded using pulse dampeners filled to five different liquid fractional volumes: 0.25, 
0.40, 0.55, 0.70, and 0.85. The inlet and outlet were in the middle and lower positions, 
respectively, and the total chamber volume was 15 mL. Relative pulsation was calculated 
as the ratio of peak-to-peak measurement divided by the mean flow rate. *At liquid 
volume ratio = 0.85, the system shows significantly higher values than the other four 
conditions (p<0.05). 
3.2.2.7. Final design and validation of high-throughput pulse dampener. 
After optimizing the prototype system, we created a final version of the device 
that has two polycarbonate dampeners with six 15mL chambers each mounted on a 
support plate. (Figure 3.8). Two ports have been machined into each chamber to allow 
the mounting of a tubing connector for interfacing the pulse dampeners with the flow 
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loop. These two multichamber blocks are made air tight with a steel plate that compresses 
a silicone seal. These multichamber blocks are attached to an underlying mounting plate 
with an indentation for mounting a multichamber flow slide. The system was designed to 
be modular, allowing each six-well flow plate to be used in isolation as experimental 
demands change. In addition, the support plate immobilizes the flow plate and simplifies 
 
Figure 3.6. Inlet/outlet configuration has a minimal effect on system pulsatility. Only 
at the high-mid configuration does inlet/outlet configuration produce a significant effect 
and only then at high flow rates. Flow waveforms were recorded using the following 
inlet-outlet configuration: high-mid, high-low, mid-mid, mid-low, and low-low. 
Recordings were performed at liquid volume ratios of 0.24 and 0.55 and the total 
chamber volume was 15 mL. Relative pulsation was calculated as the ratio of peak-to-
peak measurement to total flow rate. *At high-mid configuration, the system shows 
significantly higher values than the other four conditions (p<0.05). 
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the logistics of performing higher-throughput experiments with flow. Overall this system 
provides flow profiles for each isolated flow loop that were identical to those of the 




Figure 3.7. Optimized pulse dampener design is effective at increased viscosities. 
Using higher viscosity media has little effect on the effectiveness of the pulse dampener 
system. Flow waveforms were recorded using pulse dampeners at three different 
viscosities: 0.89, 3.5, and 7.0 cP. The inlet and outlet were in the middle and lower 
positions, respectively, and the total chamber volume was 15 mL. Relative pulsation was 




Figure 3.8. Design of low-volume pulse dampener for multichannel flow. (A) The 
dampener consists of two compliance chambers containing culture media and air. A flow 
plate with six parallel-plate flow chambers was placed between the pairs of compliance 
chambers and connected with tubing and elbow connectors. (B) Photographs of the 
assembled pulse dampener with up to 24 parallel channels. 
3.2.2.8. Comparison of pulsating flow versus steady flow in controlling endothelial cell 
response to shear stress. 
To examine the biocompatibility and utility of our multichannel flow system we 
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examined the viability and responsiveness of cultured endothelial cells to shear flow. We 
applied 20 dynes/cm2 of shear stress to HUVECs for 12 hours in the flow system without 
pulse dampeners (undamped), with a single pulse dampener or with full system with two 
dampeners. Cells exposed to the undamped flow loop were found to detach and had 80% 
less surface coverage of cells in comparison to those in the system with a single or dual 
pulse dampening unit (Figure 3.9A and 3.9B).   
Shear stress induced alterations in cellular elongation and cytoskeletal 
organization is a well-characterized response in endothelial cells. We examined the effect 
of treating cells with 20 dynes/cm2 of mean shear stress using the undamped, single-
damped and double-damped systems. Both the undamped and single-damped system 
applied pulsatile flow while the double-damped system applied steady flow. Elongation 
by flow was seen in 80% of cells exposed to steady flow in the double-damped system 
while only 40-50% of cells elongated that were exposed to pulsatile flow after 12 hours 
(Figure 3.9C). To examine the long-term compatibility of the system we applied steady 
flow using the pulse dampened system for 38 hours and found no signs of cell loss 
(Figure 3.9D). These cells had increased alignment and elongation in comparison to cells 
at the shorter time points (Figure 3.9E-G).  
We next examined the ability of the shear stress in the system to stimulate two 
well-characterized endothelial cell responses to shear stress including cytoskeletal 
remodeling and an enhancement in the production of expression of eNOS and production 
of NO85.  After 12 hours of exposure to steady flow endothelial cells in the system had 
enhanced formation of actin stress fibers and overall actin intensity (Figure 3.10A and 
3.10B). Focal adhesion formation was also enhanced under steady flow as evidenced by 
paxillin staining with most, but most prominently in the undamped system (Figure 
3.10C). Cells treated with 20 dynes/cm2 mean shear stress in the double-damped system 
also had enhancement in eNOS expression of around 2.5 fold over the static control after 
 27 
 
Figure 3.9. Cell coverage and elongation in response to steady and pulsatile shear 
stress. Mean flow of 16.3 mL/min (20 dynes/cm2) was applied to endothelial for 12 hours 
using the undamped, single-damped, and double-damped systems. (A) Phase contrast 
images of the cells after each of the flow conditions: static, undamped, single-damped, 
and double damped. Scale bar = 200µm. (B) Cell coverage is the percent area covered by 
the cells in the monolayer. The undamped system shows a significant loss in cell 
coverage during flow. (C) Cell elongation was defined as a major-to-minor axis greater 
than two. (D) Mean flow of 16.3 mL/min (20 dynes/cm2) was applied to endothelial for 
38 hours using the double-damped system. Scale bar = 50 µm. (E) Cell elongation was 
defined as the major-to-minor axis ratio. (F) Cell angle was relative to direction of flow 
and was calculated for cells with an elongation form factor > 2. (G) Cell elongation was 
defined as a major-to-minor axis greater than two. *Statistically different from all other 
groups (p < 0.05). 
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Figure 3.10. Biological validation of the double-damped flow system versus 
undamped and single-damped flow systems. (A) Fluorescence images were stained for 
actin and paxillin in each of the flow conditions: static, undamped, single-damped, and 
double-damped. Cells were treated with 20 dynes/cm2 shear stress for 12 hours. (B) 
Average actin intensity per cell was normalized to static culture levels. The double-
damped system shows a significant increase in actin levels compared to the static, 
undamped, and single-damped conditions. (C) Average paxillin intensity per cell was 
normalized to static culture levels. *Significantly lower values than the other three 
conditions (p<0.05). **Significantly higher than the single-damped system (p<0.05). (D) 
Fluorescence images were labeled with DAPI and an antibody against eNOS in each of 
the flow conditions: static, undamped, single-damped, and double-damped flow. (E) 
Steady flow increases eNOS to a greater extent than pulsatile flow. Average eNOS 
intensity per cell was normalized to static culture levels. *The double-damped system 
shows a significant increase in eNOS levels over the other conditions (p < 0.05). Scale 




12 hours of flow and at least 50% greater than that of the undamped and single-damped 
systems (Figure 3.10D and 3.10E).  
 
3.2.3. Discussion: 
Systems for studying vascular mechanotransduction in cultured cells have shown 
the importance of mechanical environment in controlling many aspects of vascular 
biology62. We sought to develop a simple, high-throughput device to allow the 
application of fluid shear stress to cultured cells that was accessible to many laboratories. 
Several main approaches have been used in the past to create flow over cells in culture. 
These include parallel-plate flow chambers65-67, flow tubes86, and cone-and-plate 
devices69,70.   We chose to pursue the parallel-plate flow chamber configuration as it 
creates flow in a format highly amenable to live cell imaging, immunofluorescent 
staining, and other common assays used in studying mechanotransduction. Parallel-plate 
flow chambers compatible with our system are available commercially and are also easily 
custom manufactured. Recently a number of microfluidic platforms have been developed 
to provide devices to study cultured cells under flow conditions73-75. The system 
developed in this work presents a very accessible means to apply steady flow in a 
multiwell format. This capability allows it to interface with existing commercially 
available flow chambers and would allow the application of long term multichannel flow 
to microfluidic chips.  
In our system, we found that at least one pulse damper was essential for 
maintaining cell viability and attachment in the closed flow loop. The likely reason for 
this finding is the reduction in maximum flow rate from the undamped system versus the 
system with a single pulse dampener. The addition of a single pulse dampener at a mean 
flow rate of 15 mL/min reduces the maximum flow rate of the system from 25 mL/min to 
around 18 mL/min. This corresponds to shift from 31 dynes/cm2 to 22 dynes/cm2 in 
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maximum shear stress. Thus, cell detachment with this high shear rate is the likely the 
cause of cell loss in the undamped system at physiological flows of 18 mL/min. 
We optimized our system to effectively remove pulsation in the flow loop at 
physiologic arterial flow rates. The compliance added into a flow system by adding a 
volume of trapped compressible gas acts as a low-pass filter, passing lower frequencies 
with greater magnitude than high frequencies87. In a peristaltic pump, the flow rate is 
increased by accelerating the rotation of the rollers and, thus, the frequency of the 
rhythmic occlusion of the tubing. Consequently, as we move to higher flow rates the 
frequency of pulsation increases. A major consequence of this pump behavior and the use 
of a capacitance as a pulse dampener is that as the mean flow rate decreases and 
frequency of pumping decreases, the pulse damping system becomes less effective. 
Therefore, for slower flow rates/pulsatility a larger compliance is needed to fully dampen 
the unsteady nature of the flow as observed in our studies. While we concentrated on 
exploring a two-dampener system, one could potentially use additional dampeners in 
series; however, we feel that this would not have a substantial advantage over increasing 
the gas volume in the compliance chamber. 
We tested the biocompatibility of our system by examining several shear-
mediated behaviors in endothelial cells. Previous studies have shown that shear stress can 
activate the eNOS pathway in endothelial cells88-92. This activity is an essential property 
of the healthy endothelium and is lost when endothelial cells become dysfunctional in 
disease93. In our study, we compared the effects of pulsatile flow versus steady flow in 
activating eNOS under the identical mean flow conditions. Our results demonstrated that 
steady flow induces a more robust increase in the eNOS expression in comparison to the 
high-frequency pulsatile flow produced by the system with a single dampener. These 
findings are consistent with those of other groups that compared eNOS mRNA 
expression and found reduced production of nitric oxide and eNOS mRNA with flow 
simulating human arterial pulsatile flow versus continuous flow88. In our study we used a 
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pulsation cycle that was about 10-15 fold faster than human arterial pulsation. While this 
is beyond the physiological heart rate of humans, the rate of pulsation from the pump 
corresponds to a heart rate of 600-900 beats per minute, a rate similar to the average or 
elevated heart rate of mice. In addition to validating the biocompatibility of our system, 
these findings also suggest that the endothelium is capable of sensing high frequency 
pulsations and can markedly alter the endothelial cell production of eNOS.  
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3.3 LARGE FORMAT DEVICE 
 Our twenty-four channel, multi-throughput shear system contains many novel 
characteristics over existing systems. It uses a minimal media volume, particularly 
important in experiments that require the addition of expensive growth factors, and can 
run many experiments in parallel that previously needed to be conducted serially. 
However, it does still have limitations. The ibidi six-channel plates the system was 
designed to work with have a minimal cell growth area. This is ideal for live or fixed cell 
imaging, but creates a poor signal-to-noise ratio for cell lysis techniques; real-time 
polymerase chain reaction (PCR) is possible, but noisy, and Western blot assays have 
produced inconsistent results. Additionally, many assays that analyze cell excretions into 
the surrounding media, such as chemokine and nitrite/nitrate assays, are a challenge. 
Therefore, we wanted to design a system that was analogous to the multi-throughput 
technology of our optimized system, but allowed for the growth of a larger number of 
cells for many of these techniques. 
 To facilitate the larger cell growth area, we took a step back and looked at the 
initial parallel-plate flow systems. These systems, which use an extracellular matrix-
coated glass slide as the substrate, allow for more than an order of magnitude increase in 
surface area. A rectangular gasket is then applied between the slide and the top plate that 
has the inlet and outlet for media flow. While traditionally done in a single channel setup, 
this system is highly compatible with the peristaltic pump/pulse dampener setup for our 
optimized system. Therefore, we designed a new baseplate and parallel-plate apparatus 
setup to allow for a twenty-four channel system that accommodates cells grown on 
standard microscopy slides. 
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3.3.1. Materials and Methods 
3.3.1.1. Device Design and Fabrication 
Design of the initial gasket and top plate were modeled after the Rectangular 
Flow Chamber Kit from GlycoTech Corporation. However, in lieu of a vacuum-based 
system, which is more complex for a multichannel setup, a top bar was designed to hold 
each ‘sandwich’ in place. Parts were designed using SolidWorks (Dassault Systèmes) and 
converted to proprietary software for fabrication by eMachineShop. A multichannel 
peristaltic pump (MCP Standard; Ismatec) with a 24 channel pump head was used to 
create flow in the system. Shear stress in the flow chambers at the cell culture surface 






where 2h is the height of the channel, 2b is the width of the channel, η is viscosity, and ϕ 
is the flow rate through the channel79.  
3.3.1.2. In Vitro Testing 
HUVECs were used between passages 4 and 6. These cells were grown in 
MCDB-131 media with growth supplements (Lonza) with a total of 7.5% FBS 
(Invitrogen). Standard 1”x3” glass microscopy slides were autoclaved and coated with 
collagen at 37°C for 1 hour before cells were seeded and grown to confluence. During the 
application of flow, the entire system was placed in an incubator and kept at 37°C and 
5% CO2.  
For immunostaining, the cells were then washed with PBS and fixed in 4% 






















































and blocked with 5% FBS for 1 hour. Next, the cells were exposed to a 1:50 dilution of 
primary antibodies for paxillin and eNOS (Santa Cruz Biotechnology) in 1% bovine 
serum albumin (BSA) overnight at 4°C. The cells were then washed three times in 
PBS/1% BSA and treated with a 1:1000 dilution of fluorescently-labeled secondary 
antibodies for 1 hour at room temperature. Finally, the cells were mounted in a hardset 
DAPI-containing mounting medium, coverslipped, and imaged using an epifluorescent 
microscope (Carl Zeiss). 
 
3.3.2. Results 
3.3.2.1. Large Format Parallel-Plate Design 
 In order to modify our original optimized system to accommodate cell-coated 
microscopy slides, we needed to a) redesign the baseplate to allow for the large surface 
area of the slides, b) design a parallel-plate ‘sandwich’ system, and c) create a system to 
secure each setup in place during experimentation. The new baseplate still includes 
attachments for the pulse dampeners but has six 1”x3” grooves for the slides. We based 
our parallel-plate ‘sandwich’ design on the Rectangular Flow Chamber Kit from 
GlycoTech Corporation. Each unit consists of a 0.01” silicone gasket with a rectangular 
hole that is placed on the cell-coated glass microscopy slide. Then, a polycarbonate top 
piece is applied which contains tapped holes and triangular grooves that function as the 
inlet and outlet for media flow. While the system from GlycoTech uses a vacuum-based 
system to hold the ‘sandwich’ together, this becomes a much more complicated endeavor 
in a multi-throughput system. Therefore, we simplified for the system by designing a top 
bar that screws into the baseplate and holds the six ‘sandwiches’ together. This design 




Figure 3.11. Large format parallel-plate flow design. (A) The design uses the pulse 
dampeners from our original device attached to a larger baseplate with recesses for 1”x3” 
microscopy slides. Silicone gaskets and top inlet/outlet pieces are held down onto the 
slides by the securing top bar and sixteen bolts. Side, Top, Exploded, and Assembled 









3.3.2.2. In Vitro Device Validation 
In order to test that the cells in the system were able to respond to shear stress in a 
manner consistent with previous studies, we cultured HUVECs on collagen-coated glass 
microscopy slides and applied a shear of 12 dynes/cm2 for 24 hours using our system. To 
test the feasibility of the system for immunostaining, the cells were fixed in 4% 
paraformaldehyde and stained fluorescently labeled for actin and eNOS. As shown in 
Figure 3.12A, our system maintains the ability of cells to align to flow and increase 
eNOS production. We later used our system to conduct shear stress experiments for 
Western blotting, such as in Figure 4.3B. 
 
 
Figure 3.12. Immunostaining with Large Format Parallel-Plate Device. HUVECs 
were exposed to 24 hours of 12 dynes/cm2 shear stress, fixed, and immunostained for 
eNOS expression and the actin cytoskeleton. Exposure to shear stress induces cell 
alignment with flow and increased levels of eNOS expression. Scale bar = 50 µm. 
 






While our initial optimized multichannel flow system improved on many of the 
issues with existing systems, we wanted to create an analogous modification that would 
allow us to address some of its own issues. Mainly, the low number of cells in the ibidi 
six-channel flow plates precludes many downstream analysis applications such as 
Western blotting and chemokine assays. Therefore, we looked back to some of the initial 
systems that used cells cultured on microscopy slides, which have an order of magnitude 
higher surface area, and sought to merge those systems with the low media requirements 
and multichannel capabilities of our system. We were able to create a system that is 
robust and compatible with our peristaltic pump/pulse dampener system and capable of 
both immunostaining and cell lysis-based (e.g. Western blot) downstream techniques. 
The new toolset allows us a new set of analysis applications with which to study 
endothelial shear mechanotransduction responses.  
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3.4 CONE-AND-PLATE DEVICE 
 Our multichannel parallel-plate flow system and larger format modification allow 
us to conduct a large range of analytical techniques to investigate the endothelial shear 
mechanotransduction response, including immunostaining, real-time PCR, Western 
blotting, and chemokine assays. One large limitation, however, is the lack of temporally 
dynamic waveforms that we can apply as the shear response. While this is technically 
feasible with a parallel-plate system, a far easier alternative is the other canonical in vitro 
shear stress tool: the cone-and-plate system. Briefly, a low-angle cone is rotated just 
above the cultured cells at a given rotational velocity. The further away the cells are from 
the center of the plate, the further the distance between the cone and the cells; however, 
the tangential velocity of the cone also increases. Thus the equation to calculate the shear 




where τ = shear stress, μ = fluid viscosity, ω = rotational speed, and θ = angle of the 
cone94. The principle benefit of this system is that the shear stress is directly related to the 
rotational speed and so a dynamic rotational speed profile translates into a dynamic shear 
stress profile. 
 Dynamic shear stress profiles have come under increased interest in recent years. 
While static culture is frequently used as a control during in vitro shear experiments, this 
is clearly not the case in atheroprone regions of the vasculature. Indeed, cultured cells 
have shown some very different responses to a low amplitude, low frequency oscillatory 
shear profile versus static conditions95. Additionally, the ability to apply dynamic 
waveforms allows for complex, physiologically accurate waveforms; Dai et al. used flow 
profiles measured from human patient’s carotid arteries via ultrasound to generate a shear 
stress waveform that recapitulates that found in the carotid artery (Figure 3.13)96. These 
complex dynamics both yield interesting new findings in the complexities of dynamic 
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mechanotransduction, but also may allow fast therapeutic design due to the use of 
specifically physiologically relevant waveforms. 
 For the design and construction of our cone-and-plate system, we aimed to take 
the important characteristics of existing systems and improve upon them in a similar 
fashion to our other machines. Our main design criteria were to create a system that: (1) 
was modular to allow for simultaneous units to run in parallel, (2) was driven by a motor 
capable of running most physiologically relevant waveforms, (3) applied shear stress to 
enough cells in culture to allow for downstream analysis techniques such as Western 
blotting, and (4) allowed for long experiment duration (at least 24 hours).  
 
Figure 3.13.  Carotid artery flow profile. Graphs of carotid artery local shear stress 






















































3.4.1. Materials and Methods 
3.4.1.1. Device Design and Fabrication 
 Parts were initially designed in SolidWorks (Dassault Systèmes) and later 
translated into the custom software for eMachineShop for fabrication. With the exception 
of the cone, which was made from 316 stainless steel, all parts were manufactured from 
aluminum. The flange was purchased from SealMaster and the motor and controls were 
purchased from Quicksilver Controls.  
3.4.1.2. In Vitro Testing 
Human umbilical vein endothelial cells (HUVECs) were used between passages 4 
and 6. These cells were grown in MCDB-131 media with growth supplements (Lonza) 
with a total of 7.5% FBS (Invitrogen). Cells were seeded onto standard 10 cm cell culture 
dishes (Corning) and grown to confluence. During the application of flow, the cone-and-
plate device was placed in an incubator and kept at 37°C and 5% CO2. The cells were 
then washed with PBS and lysed with 20mM Tris, 150mM NaCl buffer (pH 8.0) 
containing 1% Triton X-100, 0.1% SDS, 2mM sodium orthovanadate, 2mM PMSF, 
50mM NaF, and 1 complete protease inhibitor pellet (Roche) per 50mL lysis buffer. For 
Western blotting, a 1:500 dilution of primary antibodies (VCAM-1, ERK1/2, and 
GAPDH from Cell Signaling) was used for overnight incubation at 4°C and a 1:3500 
dilution of secondary antibodies (Santa Cruz Biotech) was used at room temperature for 2 
hours as previously described 97. 
3.4.2. Results 
3.4.2.1. Device Design 
 The initial design consideration we had was the dimension of the cone. The three 
major design characteristics were the material, the angle, and the width. We chose to use 
316 stainless steel due to the high level of biocompatibility, durability to reduce scratches 
and blemishes that would affect shear profile, and ease of sterilization. For the angle, we 
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elected to use a 2° angle cone due to the uniform shear profile it creates, based on 
previous computational calculations by our lab98. Finally, the width of the cone relative to 
the cell culture dish affects the volume of media that can be used during an experiment. 
We wanted to ensure that the media volume during experimental runs would not fully dry 
out due to evaporation and wicking. After calculating the maximum media volume 
possible for a range of different cone widths we finalized on 2.9” due to its maximum 
media volume of 13.8 mL. Additionally, this design leaves a clearance of 0.25” between 
the cone and the culture dish wall to allow for a media exchange system if necessary for 
longer runs. 
 The other major design consideration we had was the power requirement of the 
motor. In order to ensure optimal performance, we needed to make sure the motor we 
chose was able to produce enough power to overcome the frictional and inertial forces 
present in our most aggressive waveforms. We calculated the fluid drag force from the 
media and inertial force from accelerating the cone to a maximal shear stress level of 45 
dynes/cm2, which yielded a motor that required 0.123 Nm of torque. Based on these 
physical, as well as financial, considerations, we opted for the QCI-34L-1 motor from 
Quicksilver Controls. 
 The final design was done in SolidWorks and then converted into proprietary 
software for machining by eMachineShop (Figure 3.14A). For visual confirmation and 
conception of the design in the incubator, we used the virtual reality feature of the 
eDrawings app (SolidWorks) for Apple iPad to assess the scale and if we would be able 
to fit four modules in our incubator (Figure 3.14B). 
3.4.2.2. Fabrication, Assembly, and Calibration 
 Once the parts were machined, we assembled the cone-and-plate devices. Most of 
the assembly consists of bolts and tapped holes, but the major part that needed to be 
calibrated was the cone height. (Figure 3.15A) To ensure proper shear stress, the point of 
 42 
the cone needs to be just above the cell height. While once the cone is locked in place it 
will remain in the same spot during each experiment, we needed to devise a way to assess 
when the cone was just above the bottom of the cell culture plate. To accomplish this we 
created a rudimentary circuit using the top piece, aluminum foil, and a multimeter.  
 
Figure 3.14. Design of cone-and-plate device. (A) Side, top, exploded, and assembled 
views in SolidWorks. (B) Picture of device in incubator using the virtual reality feature 
on eDrawings app (SolidWorks) for Apple iPad. 
(Figure 3.15B). Briefly, the aluminum foil was flattened on the bottom of a cell culture 
plate and connected to the multimeter via a wire. Another wire connected the top piece to 
the multimeter. When the machine was assembled, the cone was gently lowered until it 
touched the aluminum foil, closing the circuit and creating a measureable resistance on 
the multimeter. The cone was then mechanically tapped up slightly and tested again until 
the point where the circuit was just broken. Then the cone was secured in place and the 
procedure was repeated with the remaining modules. (Figure 3.15C). 
Side View 
Top View Assembled View 
Exploded View A B 
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3.4.2.3. Initial In Vitro Testing 
 In order to validate the system, we wanted to run a simple experiment to validate 
that we could achieve one of our principle goals with the system: to use Western blotting 
techniques to analyze the effects of different dynamic shear profiles on cultured 
endothelial cells. We applied two different shear profiles, laminar shear at 12 dynes/cm2 
and oscillatory shear at ± 0.5 dynes/cm2, for four hours in addition to our static control. 
Cells were then lysed, normalized by BCA assay, and Western blotted for VCAM-1 and 
ERK1/2. GAPDH was used as a housekeeping marker to validate uniform well loading 
(Figure 3.16). The laminar shear condition had lower levels of both ERK1/2 and VCAM 
than the oscillatory and static conditions, and the GAPDH validated that we were able to 
effectively load uniform levels of protein in each well. 
 
Figure 3.15. Completed cone-and-plate devices. (A) Picture of device in incubator. (B) 




 To supplemental our existing toolbox of shear stress application devices, we 





cultured cells. In order to most simply achieve this goal, we deviated from our parallel-
plate shear stress devices in favor of a cone-and-plate model. The benefit of this system is 
that it allows us to dynamically alter the shear stress with the speed of cone rotation. 
Additionally, we had several design characteristics that we wanted to include: (1) a 
modular system, (2) the ability to run multiple waveforms, (3) applying shear to enough 
cells for downstream techniques such as Western blotting, and (4) to enable the system to 
perform for long shear runs. We have created four devices that can be run in parallel, but 
the system is only limited by the available space in a cell culture incubator. We ensured 
that the motors were able to produce the necessary power to create almost any 
physiological shear waveform. Using an in vitro pilot run we ensured that the system 
could successfully perform downstream Western blots. And finally we designed the cone 
to enable enough media for long experiments. Additionally, we have created space 
between the cone and cell culture sidewall to allow us to use our peristaltic pump as a 
media exchange system for experiments that are longer than the existing media allows. 
 
Figure 3.16. Western Blot of Initial Test Run. Four hours of 12 dynes/cm2 laminar 
shear stress lowers expression of VCAM-1 and ERK1/2 from static culture levels, while 
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Endothelial shear stress mechanotransduction in vitro experiments require 
mechanical devices that can use media to apply shear stress over endothelial cells. Our 
goal was to design machines that used the basic framework of long-established shear 
application methods and improve them to allow us to carry out experiments in parallel. 
With our first device, we created a multithroughput system that allows us to carry out 
twenty-four simultaneous experiments in parallel while reducing the necessary media 
requirements for each by more than an order of magnitude over most conventional 
parallel-plate systems. The modified second version allows for shear over a larger 
number of cells to facilitate Western blotting and chemokine assays. Finally, our cone-
and-plate devices can produce dynamic waveforms to investigate the temporal effects of 
physiological shear waveforms. Overall these devices give us a powerful toolset to allow 









Chapter 4: In Vitro Effects of Syndecan-12 
 
4.1 INTRODUCTION 
Arterial mechanotransduction has been the subject of intense experimental and 
theoretical study over the past decades23,28. The search for potential mechanotransducers, 
molecules that serve as force sensors and activators of mechanical responses, has 
revealed a variety of intricate mechanisms through which hemodynamic forces can alter 
arterial biology30-32,99,100. A key finding in these studies is that certain arterial flow profiles 
induce an atheroprotective phenotype in endothelial cells leading to broad alterations in 
endothelial function relating to inflammation, vasodilation, and thrombosis whereas other 
profiles induce a more inflammatory, atheroprone phenotype23. Multiple signaling and 
transcriptional regulators, such as the Krüppel-like factor (KLF) family of transcription 
factors, have been found to strongly modulate this response101-104. Several key 
mechanosensitive elements have been identified in endothelial cells, including platelet 
endothelial cell adhesion molecule (PECAM-1), cadherins, and the actin cytoskeleton105, 
but the full scope and complexity of the mechanosensing mechanisms remains unclear. 
The endothelial glycocalyx is a structure of glycans and proteoglycans present on 
the luminal surface of arteries. Recent cryo-electron microscopy images have shown that 
it can extend up to 11 μm into the lumen, inevitably making it the endothelial structure 
first exposed to changes in fluid shear stress106. In addition, modeling studies have 
postulated that the entirety of fluid shear force is dissipated in the glycocalyx before 
                                                
2 Some work contained in this chapter was previous published in the following journal article: Voyvodic, P. 
L., et al. Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated 
response to atheroprotective flow. Journal of Biological Chemistry 289 (14), 9547-9559, doi: 
10.1074/jbc.M113.541573 (2014). The individual contributions by the authors are as follows: Peter L 
Voyvodic- Principle author and conductor of the research; Daniel Min- Undergraduate research assistant to 
PL Voyvodic; Robert Liu- Undergraduate research assistant to PL Voyvodic; Evan Williams- 
Undergraduate research assistant to PL Voyvodic; Vipul Chitalia- Helped design lentiviral mutants to used 
to produce pSyn1 line; Andrew K Dunn- No contribution in Chapter 4; Aaron B Baker- Supervisor to PL 
Voyvodic. 
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reaching the cell membrane107. Removal of heparan sulfate glycoaminoglycans from the 
cell surface using enzymatic digestion reduces endothelial production of vasodilatory 
factors in response to shear stress48. However, it is unknown which proteoglycans are 
important in these processes and their scope of mechanistic involvement in 
mechanosensing of shear stress.  
The syndecan family of transmembrane cell surface proteoglycans are an 
appealing group of candidate molecules for mechanosensing owing to their location at the 
cell surface and interactions with integrins and cytoskeletal elements108. The syndecans 
are single-pass transmembrane proteins known to be capable of transmitting extracellular 
signals into intracellular signaling pathways109. These molecules are a component of the 
glycocalyx and are likely exposed to extracellular forces from flow and adherence to the 
extracellular matrix. In addition, the cytoplasmic domain of syndecans interact with 
cytoskeletal and focal adhesion complex proteins as well as multiple intracellular 
signaling pathways110. The syndecans act synergistically with integrins through their 
extracellular domain and serve as regulators of cell adhesion111-113. Thus, syndecans and 
other cell surface proteoglycans are uniquely positioned to interact with externally 
applied mechanical forces and transmit these signals to multiple pathways within the cell. 
We hypothesized that syndecan-1 is a critical element in shear stress-mediated 
signaling and phenotypic regulation in endothelial cells. Using endothelial cells isolated 
from sdc-1 knockout mice, we demonstrate that sdc-1 is required for the activation of Akt 
and RhoA and for the formation of a phosphorylation gradient in paxillin in the initial 
stages of the endothelial response to shear stress. In addition, sdc-1 knockout profoundly 
alters the shear stress induced expression of transcription factors, vasodilatory mediators, 
and inflammatory soluble factors and receptors. Based on these findings, we propose that 
sdc-1 is an important atheroprotective molecule that governs both the inflammatory state 
of the endothelial cells and the induction of atheroprotective phenotypes by shear stress. 
Thus, this work expands our limited understanding of the role of cell surface 
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proteoglycans in vascular mechanobiology and may provide insight into the mechanisms 
of shear stress-mediated regulation of atherogenesis. 
 
4.2. MATERIALS AND METHODS 
4.2.1. Cell Culture. 
Endothelial cells were isolated from the lungs of wild-type (WT) and syndecan-1 
knockout (S1KO) mice as previously described114. Briefly, the lungs were macerated and 
digested with collagenase followed by sorting with CD31 Dynabeads (Invitrogen). After 
cells were expanded, they underwent a second round of CD31 Dynabead sorting to 
ensure cell purity. Endothelial phenotype was confirmed using cellular uptake of 
fluorescently labeled Ac-LDL and through the expression of Tie-2 mRNA. Cells were 
later examined for size differences due to loss of sdc-1 (Figure 4.1). Area was calculated 
using Metamorph software (Molecular Devices) of over forty cells for both wild type and 
sdc-1 knockout cells. Volume was measured using a Z-series Coulter Counter (Beckman 
Coulter). We also measured gene expression to evaluate compensatory increases in other 
heparan sulfate proteoglycan core proteins and synthetic enzymes (Figure 4.2). The cells 
were cultured in MCDB-131 media with 5% fetal bovine serum (FBS) and antibiotics 
(Invitrogen). Experiments using human synstatin (GenScript) were performed at 3 μM 
synstatin on HUVECs grown in MCDB-131 media with growth supplements (Lonza) 




Figure 4.1. Loss of sdc-1 results in reduced cell size and adhesion area. (A) S1KO 
endothelial cells adhered to a smaller surface area than the WT cells (n > 40). *p < 0.05 
for S1KO versus WT group. (B) The volume of S1KO cells is reduced compared to the 
WT model. 
4.2.2. Cloning of lentiviral constructs for expressing wild type and mutant forms of 
syndecan-1 and expression in endothelial cells.  
To allow robust expression in primary vascular cell lines we cloned the sdc-1 
gene into an enhanced lentiviral expression system115 (kind gift of Dr. Gustavo 
Mostoslavsky, Boston University) and validated the expression of sdc-1 in endothelial 
cells (pSyn1). This lentiviral system is highly efficient in infecting vascular cells and led 
to over 99% efficiency of cells as measured by constitutive expression of GFP through an 
internal ribosome entry site (IRES) promoter incorporated into the vector. The construct 
was confirmed by DNA sequencing and nuclease digestion. The lentiviral vector was 
then transfected with packaging vectors into a HEK-293T packaging line to allow viral 
production and transduced into cells as previously described115.   
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Figure 4.2. Loss of sdc-1 alters the expression of other glycocalyx components and 
heparan sulfate sulfotransferases. WT and S1KO endothelial cells were lysed under 
static conditions and examined for gene expression (n = 6). (A) S1KO endothelial cells 
express higher levels of other glycocalyx components, particularly sdc-4 and gpc-1. *p < 
0.05 for S1KO versus WT group. (B) Expression of sulfotransferases was dramatically 
increased in the S1KO model. *p < 0.05 for S1KO versus WT group. Abbreviations used 
are as follows: Sdc2, syndecan-2; Sdc4, syndecan-4; Gpc1, glypican-1; Ndst2, N-
deacetylase/N-sulfotransferase (heparan glucosaminyl) 2; Hs2st1, heparan sulfate 2-O-
sulfotransferase 1; Hs3st1, heparan sulfate glucosamine 3-O-sulfotransferase 1; Hs6st1, 
heparan sulfate 6-O-sulfotransferase 1. 
4.2.3. In-Vitro Flow Studies. 
For Western lysis flow experiments, cells were seeded onto glass slides coated 
with fibronectin; for all other flow experiments, cells were seeded into multichannel flow 
chambers (μ-Slide VI0.4; ibidi, LLC). Flow was applied using our multichannel flow 
device that provides steady flow in up to 24 flow channels simultaneously as previously 
described116. The entire system was kept in an incubator at 37 °C with a 5% CO2 
atmosphere throughout the experiment.   
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4.2.4. Immunocytochemical Staining. 
Following treatments, the cells were washed with PBS and fixed in 4% 
paraformaldehyde for 20 minutes. The cells were quenched with 0.2M glycine and then 
permeabilized with 0.2% Triton X-100 and blocked with 5% FBS in PBS/1% bovine 
serum albumin (BSA) for 1 hour. Next, the cells were labeled with a 1:100 dilution of 
primary antibodies in PBS/1%BSA overnight at 4°C. They were then washed three times 
in PBS/1%BSA and labeled with a 1:1000 dilution of fluorescently labeled secondary 
antibody for 1 hour at room temperature. For experiments studying the actin 
cytoskeleton, the cells were also labeled with a 1:500 dilution of Alexa 594-labelled 
phalloidin (Invitrogen) for 1 hour at room temperature. Finally, the cells were washed 
five times in PBS/1%BSA, mounted in a DAPI-containing mounting medium (Vector 
Labs) and imaged using an epifluorescent microscope (Carl Zeiss). Morphometric and 
intensity analysis of the cells was performed using Metamorph software (Molecular 
Devices) and Photoshop software (Adobe). The following antibodies were used for 
immunostaining:  phospho-Akt (Ser473) and Akt from Cell Signaling; phospho-paxillin 
(Tyr118) from Invitrogen; paxillin from BD Biosciences; and secondary antibodies from 
Santa Cruz Biotechnology. Activation of integrin αvβ3 was detected with the WOW-1 
antibody using a 1:5 dilution (kind gift of Dr. Shattil Sanford, UCSD). 
4.2.5. Cell Lysis and Immunoblotting. 
Following treatments, the cells were lysed with 20mM Tris, 150mM NaCl buffer 
(pH 8.0) containing 1% Triton X-100, 0.1% SDS, 2mM sodium orthovanadate, 2mM 
PMSF, 50mM NaF, and 1 complete protease inhibitor pellet (Roche) per 50mL lysis 
buffer. For Western blotting, a 1:500 dilution of primary antibodies (phospho-Akt 
(Ser473) and Akt from Cell Signaling) was used for overnight incubation at 4°C and a 
1:3500 dilution of secondary antibodies (Santa Cruz Biotech) was used at room 
temperature for 2 hours as previously described 97.  
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4.2.6. Focal Adhesion Quantification.  
Fluorescent images were acquired for endothelial cells immunostained for paxillin 
and phosphorylated paxillin. The images were background subtracted and the phospho-
paxillin image was divided by the total paxillin image using Photoshop (Adobe). The 
greyscale image was then indexed and assigned to a linear psuedocolor lookup table with 
a value of 0 assigned to black to differentiate the cell from the background. Linescans of 
the greyscale ratio image were generated using Metamorph software. 
4.2.7. Colocalization Analysis. 
Following flow, images were acquired from stainings for actin and a high-affinity 
form of integrin αvβ3 using the WOW-1 antibody. Pearson correlation coefficients were 
calculated for 10 cells in each condition using ImageJ open source software and plug-ins 
developed by the Bob and John Wright Cell Imaging Facility of the University of Ontario 
Canada (www.uhnresearch.ca/facilities/wcif/fdownload.html). 
4.2.8. Measurement of RhoA activity using FRET. 
The plasmid for the RhoA-FRET Biosensor construct was used as previously 
described (pBabe-Puro-RhoA Biosensor; Addgene)117. The plasmid was transfected into 
packaging HEK293T cells using Lipofectamine 2000 (Invitrogen) to produce 
retroviruses. Viruses were collected after 48 hours, centrifuged to remove cell debris, 
filtered with a 0.45 μm filter, and added at a 50% final concentration to WT or S1KO 
endothelial cells. Media was replaced after 24 hours and the cells were given 48 hours to 
recover before undergoing resistance selection with 1 μg/mL puromycin for 10 days 
followed by selection with 10 μg/mL puromycin for an additional 10 days. During 
selection and routine cell culture, the media contained 10 μg/mL doxycycline to suppress 
RhoA construct transcription through a TetCMV repressor. At 48 hours prior to the 
experiment, the cells were given media without doxycycline to allow for RhoA construct 
transcription. The cells were seeded in flow chambers (μ-Slide VI0.4, ibidi) and grown to 
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confluence. Using a syringe pump (Kent Scientific), media was flowed over the cells 
until the given time points, at which point the channel was immediately read using a plate 
reader (Varioskan; Thermo-Scientific). To prevent alterations in RhoA activation due to 
starting and stopping flow, separate flow channels were used for each time point. The 
FRET ratio was calculated by dividing the FRET signal (Excitation: 436 ± 12nm; 
Emission: 535 ±12nm) by the donor signal (Excitation: 436 ± 12nm; Emission: 470 ± 
12nm) and then normalizing to the acceptor signal (Excitation: 500 ± 12nm; Emission: 
535 ± 12nm) to account for changes in copy number. 
4.2.9. Measurement of Gene Expression by Real Time PCR. 
Messenger RNA was harvested from the cells following flow using an RNAeasy 
kit (Qiagen) and the relative mRNA copy numbers were quantified using real time PCR 
as described previously118,119.  Copy numbers were normalized to GAPDH gene 
expression. 
4.2.10. Assay for Monocyte Adhesion. 
Confluent monolayers of WT, S1KO and pSyn1 endothelial cells were grown in 
slide mounted flow chambers (ibidi) and then stimulated with the addition of 10 ng/mL 
TNF-α for 4 hours. The flow chambers were positioned on a inverted microscope and 
CellTracker dye (Invitrogen) labeled THP-1 cells (5 x 105 cells/mL) were perfused 
through the chamber with a syringe pump (Kent Scientific) for 5 min at a controlled flow 
rate to generate a shear stress of 0.5 dynes/cm2. The entire period of perfusion was 
recorded as a digital video and analyzed to determine the number of rolling THP-1 cells 
over monolayers in three 90-second intervals. After 5 min the flow was changed to 
MCDB-131 media to wash out unadhered cells and the plates were imaged in 8 separate 
locations. The number of cells adhered per field of view was by quantified using 
Metamorph software. 
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4.2.11. Statistical Analysis. 
All results are shown as mean ± SEM. Comparisons between groups were 
analyzed using a 2-way ANOVA followed by a Tukey post-hoc test. Comparisons 
between only two groups were analyzed using a Student’s t-test. A 2-tailed probability 
value <0.05 was considered statistically significant. 
 
4.4. RESULTS 
4.4.1. Loss of syndecan-1 in endothelial cells inhibits the activation of Akt in 
response to shear stress. 
Shear stress rapidly activates the Akt pathway in endothelial cells leading to 
alterations in oxidative stress120, suppression of apoptotic signaling pathways121, and 
production of nitric oxide (NO)122. We applied shear stress to endothelial cells using a 
custom, in vitro system allowing the application of steady flow of culture media through 
24 microchannels simultaneously116. Using this system, wild-type (WT) and sdc-1 
knockout (S1KO) endothelial cells were exposed to 12 dynes/cm2 of steady shear stress 
for 15 minutes. This level of steady shear stress induces an atheroprotective phenotype in 
endothelial cells that has been well-characterized23. After 5 to 15 minutes of exposure to 
flow, wild-type endothelial cells had a robust increase in Akt phosphorylation with an 
approximately two-fold increase in Akt phosphorylation following flow as measured by 
immunostaining (Figure 4.3A) and western blotting (Figure 4.3B). In contrast, there was 
minimal activation in sdc-1 knockout endothelial cells by flow.  
4.4.2. Syndecan-1 knockout abrogates the formation of a phosphorylation gradient 
in paxillin following flow. 
Endothelial cells are known to modulate their cytoskeletal arrangement and 
alignment in response to shear stress through the formation of a gradient in paxillin 
phosphorylation across the cell123. We grew endothelial cells in flow chambers and 
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exposed them to 12 dynes/cm2 of shear stress for 15 minutes. We immunostained for 
paxillin and phospho-paxillin and performed a ratiometric analysis for paxillin 
phosphorylation from these images. There was a robust formation of a paxillin 
phosphorylation gradient in the WT cells with higher phosphorylation on the downstream 
edge of the cell after flow exposure (Figure 4.4A and 4.4B).  In contrast, there was no 
discernable polarity to paxillin phosphorylation for sdc-1 knockout cells in all cases. 
4.4.3. Loss of syndecan-1 results in reduced co-localization of activated αvβ3 
integrins with the actin cytoskeleton under static and atheroprotective flow 
conditions. 
Activation of focal adhesions is an important shear-mediated 
mechanotransduction pathway and involves accompanying activation of integrins and 
their association with the actin cytoskeleton23. Integrin αvβ3 is activated by shear stress in 
endothelial cells adhered to fibronectin or fibrinogen124 and controls the release of 
endothelial elastase and FGF-2 in response to flow125. We exposed confluent endothelial 
cells to 12 dynes/cm2 for 5 minutes and imaged activated integrin αvβ3 using the WOW-1 
antibody that recognizes the high affinity form of αvβ3126. Wild type endothelial cells had  
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Figure 4.3.  Loss of sdc-1 alters shear stress-induced activation of Akt pathway 
signaling. (A) WT and S1KO endothelial cells were exposed to flow at 12 dynes/cm2 for 
5 minutes. Immunohistochemical staining demonstrated an increase in Akt 
phosphorylation (Ser473) in WT cells after flow. In contrast this increase was not 
observed in the S1KO cells. Scale bar = 50mm. Chart displays semi-quantitative analysis 
of pAkt staining intensity (n = 40). *Statistically significant difference versus all other 
groups (p < 0.05). (B) Western blotting analysis of lysed cells following 15 minutes of 
flow at 12 dynes/cm2 revealed a reduced relative phosphorylation of Akt in S1KO cells (n 
= 8). *Statistically significant difference versus all (p < 0.05). 
co-localization between the activated αvβ3 integrins and the actin stress fibers, 
particularly at the periphery of the cell both under static and flow conditions (Figure 
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4.4C and 4.4D). This co-localization was markedly reduced in sdc-1 knockout cells 
under both of these conditions.  
 
 
Figure 4.4. Loss of sdc-1 alters shear stress-induced formation of intracellular 
spatial gradients in paxillin phosphorylation and reduces active integrin αvβ3 
association with actin. (A) WT and S1KO endothelial cells were exposed to flow at 12 
dynes/cm2 for 15 minutes. Immunostaining for phospho-paxillin and total paxillin under 
static and flow conditions shows that WT cells developed a gradient in paxillin 
phosphorylation across the cell whereas S1KO cells did not. Scale bar = 50μm (Mag = 25 
μm). (B) Line scans of p-paxillin/total paxillin ratio under static and flow illustrate the 
gradient in paxillin phosphorylation. (C) Actin stress fiber formation and elongation of 
the cells resulted from 5 minutes of flow exposure in WT cells. In these cells, activated 
αvβ3 (WOW-1 staining) was co-localized with actin stress fibers, particularly at the 
periphery of the cell. Knockout of sdc-1 reduced this association under both static and 
flow conditions. Scale bar = 50 μm (Mag = 5 μm). (D) Co-localization analysis for 
WOW-1 and actin staining following exposure to flow (n = 10). *Statistically significant 
difference versus WT static and flow conditions (p < 0.05). 
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4.4.4. Syndecan-1 knockout inhibits RhoA activation by shear stress. 
Activation of RhoA GTPases is a key step regulating endothelial cytoskeletal 
remodeling in response to shear stress127-129. To measure RhoA activity, we transduced 
WT and sdc-1 knockout cells with a retrovirus expressing a RhoA Biosensor117. The 
biosensor consists of a single peptide chain containing a Rho-binding domain (RBD), 
cyan fluorescent protein (CFP), a randomized linker, yellow fluorescent protein (YFP), 
and RhoA. When RhoA binds GTP and is activated, it binds to the RBD and increases the 
FRET efficiency between CFP and YFP. We exposed endothelial cells to flow and 
rapidly measured the RhoA activity using a fluorescence plate reader. A time course of 
RhoA activity in WT endothelial cells revealed an initial drop in activity followed by an 
increase to maximum activation after 15 minutes of flow (Figure 4.5). In sdc-1 knockout 
endothelial cells exposed to identical flow conditions, there was an initial drop in RhoA 
activity followed by a return to baseline levels of activity.  
 
Figure 4.5. Loss of sdc-1 alters shear stress-induced activation of RhoA. Endothelial 
cells were transduced with a RhoA FRET biosensor construct and exposed to flow at 12 
dynes/cm2. The WT cells exhibited a rapid drop in RhoA activity followed by an 
increase in activity. In contrast, S1KO cells had a rapid drop in activity without a 
following increase in activity (n = 6). *Statistically significant difference versus WT 
group at the same time point (p < 0.05). 
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4.4.5. Long-term exposure to flow produces a pro-atherosclerotic phenotype in 
syndecan-1 knockout cells. 
The powerful atheroprotective effects of moderate levels of shear stress result 
from a broad regulation of genetic programs in endothelial cells that induces an athero-
resistant phenotype. Members of the Krüppel-like factor (KLF) family of transcription 
factors are key regulators of shear stress-induced changes in endothelial phenotype and 
are involved in modulation of vasomotor tone, inflammation, and thrombosis101-104. KLF-
2 and KLF-4 have been found to upregulate genes that are atheroprotective101-103. In 
contrast, KLF-5 activates pro-inflammatory gene expression in endothelial cells and 
injured arteries104,130.  We applied 12 dynes/cm2 of shear stress to endothelial cells for 24 
hours and measured the gene expression of the KLF transcription factors, vasoregulatory 
factors, angiogenic factors, and inflammatory mediators. S1KO endothelial cells 
expressed reduced amounts of KLF-2 and KLF-4 in comparison to WT cells under static 
and flow conditions (Figure 4.6A). In addition, treatment with flow reduced expression 
of KLF-5 in WT cells but not in S1KO cells (Figure 4.6A). There was decreased 
expression of vasodilatory factors under atheroprotective flow in S1KO endothelial cells 
including the genes for endothelial nitric oxide synthase (eNOS), c-natrietic peptide 
(CNP), and argininosuccinate synthase (ASS) (Figure 4.6B). Angiogenesis related gene 
expression was increased in S1KO endothelial cells for Tie-2 under static conditions and 
angiopoietin-2 (Ang2) under both flow and static conditions (Figure 4.6C). In addition, 
gene expression for elastin was increased by over 100-fold in S1KO cells under static and 
flow conditions.  
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Figure 4.6. Syndecan-1 alters gene expression for transcription factors, vasodilatory 
mediators, and angiogenesis factors induced by shear stress. WT and S1KO 
endothelial cells were exposed to static conditions or flow at 12 dynes/cm2 for 24 hours. 
(A) Gene expression for the flow-inducible transcription factors KLF-2 and KLF-4 was 
decreased for sdc-1 knockout endothelial cells while KLF-5 expression was increased. 
(B) Expression of vasodilatory factors was reduced in sdc-1 knockout cells under 
atheroprotective flow conditions. (C) Expression of angiogenesis mediators was 
increased in sdc-1 knockout cells. *p < 0.05 for S1KO versus WT group under same 
static/flow conditions. Abbreviations used are as follows: KLF, Krüppel-Like Factor; 
eNOS, endothelial nitric oxide synthase; CNP, c-natriuretic peptide; ASS, 
argininosuccinate synthetase; Tie2, angiopoietin-1 receptor; Ang2, angiopoietin-2.  
4.4.6. Syndecan-1 knockout alters inflammatory cytokine expression. 
We exposed WT and S1KO endothelial cells to 24 hours of laminar flow at 12 
dynes/cm2 and measured the expression of inflammatory cytokines using real time PCR 
and ELISA. For a subset of these factors including CXCL2, IL-1α, IL-6 and COX-2 we 
observed lower levels of cytokine expression under static condition but equal amounts of 
expression between WT and S1KO cells after exposure to flow (Figure 4.7A). We found 
 61 
increased expression of CCL-5, IL-15, IP-10 and SDF-1 for S1KO cells under either 
static or flow conditions or both (Figure 4.7B). Following exposure to atheroprotective 
flow, we found increased gene expression for CXCL1, MCP-1 and MIP1-γ (Figure 
4.8A). We performed an ELISA for these cytokines on the conditioned media after flow 
and found they were increased in S1KO cell condition media (Figure 4.8B).  
 
 
Figure 4.7. Syndecan-1 knockout alters baseline and flow-induced cytokine 
expression. WT and S1KO endothelial cells were exposed to steady flow at 12 
dynes/cm2 for 24 hours. Subsequently, mRNA was isolated and analyzed by real time 
PCR. (A) Under static conditions S1KO cells had low expression of some inflammatory 
cytokines including CXCL2, IL-1α, IL-6, and COX-2. These differences were abolished 
with exposure to flow. (B) Other inflammatory factors were increased under static and/or 
flow conditions for S1KO cells. *p < 0.05 for S1KO versus WT group under same 
static/flow conditions. Abbreviations used are as follows: CXCL, chemokine (C-X-C 
motif) ligand; IL, interleukin; COX-2, cyclooxygenase-2; CCL-5, chemokine (C-C motif) 
ligand 5; IP-10, interferon gamma-induced protein-10; SDF-1, stromal cell-derived 
factor-1. 
4.4.7. Syndecan-1 knockout increases expression of cell adhesion receptors involved 
in leukocyte adhesion and increases adhesion of cultured monocytes under flow. 
Having observed increased expression of inflammatory factors in sdc-1 knockout 
cells, we next examined whether there was regulation of cell adhesion receptors for 
leukocyte recruitment and a functional difference in the adhesion of monocytes to 
activated endothelial cells. Under static and atheroprotective flow conditions we found a 
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200-300 fold increase in ICAM-1 expression in S1KO cells in comparison to WT cells 
(Figure 4.9A). Under atheroprotective flow, S1KO cells had over four-fold more 
VCAM-1 gene expression. In addition, we created a lentiviral vector containing the sdc-1 
gene and transduced the S1KO line with this construct (pSyn1). While ICAM-1 levels 




Figure 4.8. Syndecan-1 knockout increases gene expression and protein levels of 
leukocyte recruiting inflammatory soluble factors. WT and S1KO endothelial cells 
were exposed to steady flow at 12 dynes/cm2 for 24 hours. Subsequently, mRNA was 
isolated and analyzed by real time PCR. (A) Gene expression for leukocyte recruiting 
inflammatory mediators was increased in sdc-1 knockout cells under flow. *p < 0.05 for 
S1KO versus WT group under same static/flow conditions. (B) Levels of the 
inflammatory factors were assessed in the culture media following 24 hours of flow using 
ELISA. *Statistically significant difference (p < 0.05) for S1KO versus WT cells. 
Abbreviations used are as follows: CXCL1, chemokine (C-X-C motif) ligand-1; MCP-1, 
monocyte chemotactic protein-1; MIP1-γ, macrophage inflammatory protein 1 gamma.  
We next examined the functional consequences of sdc-1 knockout on monocyte 
adhesion in-vitro. We fluorescently-labeled cultured monocytes and measured their 
adhesion to a TNF-α stimulated endothelial monolayer under flow conditions (0.5 
dynes/cm2 for 5 min). About 50-fold more monocytes adhered to S1KO endothelial  
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Figure 4.9. Monocyte adhesion and macrophage recruitment are increased in sdc-1 
knockout endothelial cells. (A) WT and S1KO endothelial cells were exposed to 24 
hours of flow at 12 dynes/cm2. Gene expression for cell adhesion receptors was higher in 
the S1KO cells compared to WT cells following flow exposure. *p < 0.05 in comparison 
to all other groups in static or flow; **p < 0.05 in comparison to WT in static or flow. (B) 
Suspension cultured monocytes were fluorescently labeled and flowed over confluent 
endothelial monolayers of WT, S1KO, or S1KO cells transduced to overexpress sdc-1 
(pSyn1) under flow creating 0.5 dynes/cm2 of shear stress for 5 minutes. Prior to the flow 
adhesion assay the endothelial cells were stimulated with TNF-α for 4 hours. Size bar = 
200 μm. (C) Leukocyte adhesion was increased in sdc-1 knockout cells and re-expression 
of sdc-1 in these cells decreased the number adhering leukocytes (n = 8). *p < 0.05 in 
comparison to all other groups. (D) The number of rolling monocytes over three 90-
second intervals shows increased leukocyte rolling on sdc-1 knockout cells over both WT 
and pSyn1 cell line. *Statistically different from all other groups (p < 0.05).  
monolayers than to WT monolayers under identical flow conditions (Figure 4.9B and 
4.9C). More cells were also observed to roll on S1KO monolayers during the flow 
adhesion assay (Figure 4.9D). Overexpression of sdc-1 in the knockout cells using 
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lentiviral transduction reduced the number of adhered monocytes by about half in 
comparison to S1KO cells (Figure 4.9C and 4.9D).  
4.4.8 Inhibiting syndecan-1 activation of integrins does not affect endothelial 
mechanotransduction response. 
 Finally, we took a mechanistic analysis of how syndecan-1 influences endothelial 
mechanotransduction. Using a synthetic peptide, synstatin, that blocks syndecan-1’s 
ability to activate αvβ3 and αvβ5 integrins, we exposed HUVECs to 24 hours of shear 
stress and looked at gene expression levels of different inflammatory mediators and 
vasodilatory compounds (Figure 4.10). We found that blocking syndecan-1’s ability to 
activate integrins was not responsible for the changes in shear stress behavior that we saw 
in our syndecan-1 knockout in vitro experiments.  
 
 
Figure 4.10. Inhibition of syndecan-1 integrin activation does not alter endothelial 
mechanotransduction response. HUVECs were exposed to 24 hours of flow at 12 
dynes/cm2 with 3 μM synstatin or control media. Gene expression in static or flow 
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4.5. DISCUSSION 
While the role of cell surface proteoglycans in shear stress sensing has been 
suspected for many years28 there have been no studies, to our knowledge, that have 
examined their function in a mechanistic and detailed fashion. The primary experimental 
approach in studies to date has been to digest particular glycosaminoglycans of the 
glycocalyx using enzymes and to apply shear stress to interrogate whether the shear 
sensing of endothelial cells has changed from this treatment. Using this method, several 
studies have shown that shear stress-induced production of nitric oxide (NO) is reduced 
following enzymatic digestion of heparan sulfate or hyaluronic acid or treatment with 
neuraminidase48,49. In contrast, shear-induced increases in prostacyclin-2 (PGI2) were not 
affected by removal of heparan sulfate, sialic acid, chondroitin sulfate, or hyaluronan131. 
In vivo studies have also supported the involvement of proteoglycans in controlling shear 
stress-induced arterial vasodilation. Increases in blood flow cause arteries to dilate in an 
endothelium-dependent manner50,51. Several studies have supported the role of elements 
of the glycocalyx in the control of the shear-induced vasodilatory response of arteries. 
Another study examined the vasoconstriction of rabbit femoral arteries in ex vivo organ 
culture and found that incubation with neuraminidase, an enzyme that digests sialic acid 
moieties, reduced shear stress-induced NO release52. In addition, treatment with clinical 
levels of heparin led to a reduction in the duration of vasodilation in response to 
occlusion-induced reactive hyperemia in mice132. Our study adds to these results by 
defining several of the activities of sdc-1 in the initial steps of mechanosensing and in the 
regulation of endothelial phenotype.   
We first examined the role of sdc-1 in the acute mechanosensing of shear stresses 
by endothelial cells. Interestingly, without sdc-1 endothelial cells were not able to 
activate Akt and RhoA nor develop a paxillin phosphorylation gradient in response to 
flow. These signaling events have been shown in previous studies to be key to flow-
induced changes in endothelial alignment123 and cytoskeletal remodeling127-129 as well as 
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the regulation of oxidative stress120, cell survival121, and production of NO122. Our study 
also examined the longer-term effects of shear stress on endothelial cells in the absence 
of sdc-1 expression. Under atheroprotective flow, S1KO cells had decreased expression 
of atheroprotective transcription factors KLF-2 and KLF-4. These transcription factors 
regulate a set of genetic programs that profoundly alter the endothelial cell phenotype 
affecting pathways involved in inflammation, vasodilation, and thrombosis101-103. In 
contrast we found that KLF-5 expression was higher in S1KO endothelial cells after 
exposure to flow. This transcription factor has been linked to increased inflammation in 
endothelial cells104,130. Thus, the loss of sdc-1 alters the relative expression of KLF 
transcription factors and their regulation by atheroprotective flow. Consistent with these 
findings, S1KO cells had increased expression of pro-inflammatory genes, cytokines, and 
leukocyte adhesion receptors in comparison to WT cells. The functional result of these 
alterations in endothelial genetic programs was an increased leukocyte adhesion. 
Taken together, our results suggest an atheroprotective role for sdc-1 with its 
expression supporting flow-mediated mechanosensing and the generation of the 
atheroprotective phenotype.  Loss of sdc-1 also induced significant differences in 
baseline levels of many markers of endothelial phenotype. In the absence of flow, we 
found decreased levels of gene expression for KLF-4, CNP, ASS-1, Ang-2, and several 
of the inflammatory cytokines including CXCL1 and CXCL2. In contrast, under static 
conditions there was significantly increased gene expression for elastin, CCL-5, IL-15, 
IP-10 and ICAM-1. Thus, the effect of sdc-1 loss on flow-mediated signaling and 
phenotypic regulation should not be viewed as a simple effect of altered endothelial 
mechanotransduction but in the context of significant dysregulation of endothelial cell 
phenotype under baseline conditions. Interestingly, our experiments using synstatin 
suggest that this response is not due to integrin activation by syndecan-1. It should also 
be noted that the loss of sdc-1 leads to an increase in gene expression of the other 
glycocalyx components, specifically sdc-4 and gpc-1, as well as numerous 
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sulfotransferases involved in heparan sulfate synthesis. We believe this to be a 
compensatory mechanism; however, the mechanotransduction effects we observed 
despite this response further highlight the importance of sdc-1 in signal transduction. 
Several recent studies have found results that are consistent and complementary to 
our findings here. Notably, a recent study identified that, among several proteoglycan 
core proteins, sdc-1 expression was specifically reduced in endothelial cells on exposure 
to atheroprone regimes of flow and increased under atheroprotective flow conditions133. 
Viewed from the context of our results these findings would suggest that regulation of 
sdc-1 by flow could contribute to atherosclerosis and the development of endothelial 
dysfunction. In addition, another study found that the glycocalyx in sdc-1 knockout mice 
was thinner than in WT mice using intravital microscopy60. They also observed an 
increased number of leukocytes adhered in the venules of the mice, consistent with our 
findings of increased leukocyte adhesion in vitro.  In the context of these results, our 
studies support that loss of sdc-1 stimulated by exposure to atherogenic flow profiles 
would lead endothelial cells to adopt an atheroprone phenotype that is both pro-
inflammatory and resistant to the anti-inflammatory stimulus of moderate shear stress.  
Our findings also have several important implications for the understanding of 
vascular biology in the context of atherogenesis and inflammation. Sdc-1 and the other 
syndecan family members are highly sensitive to proteolytic degradation and shedding134. 
Thus, our findings imply that disease-induced increases in proteolytic activity leading to 
shedding of sdc-1 from the surface may alter endothelial inflammatory phenotype and 
shear sensitivity to atheroprotective flow. We have recently found that Ob/Ob mice given 
a high fat diet have lower levels of sdc-1 protein in their heart and skeletal muscle135. In 
addition, sdc-1 is a target for heparanase activity and leads to shedding from the cell 
surface136. Our group has recently identified a key role for the enzyme heparanase in 
restenosis and thrombosis in vascular injury137,138. We also found increased heparanase 
expression in severe atherosclerotic plaques and in arterial segments of the coronary 
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vessels with low shear stress in a diabetic, hyperlipidemic porcine model of 
atherosclerosis118. This finding has recently been corroborated in atherosclerotic plaques 
from human patients139. Another study has also identified heparanase to be key in 
controlling the inflammatory response in sepsis through degradation of the glycocalyx140. 
Thus, our findings suggest that heparanase/protease-induced shedding of sdc-1 could lead 
to modulation of endothelial phenotype and inflammatory properties potentially similar to 
our sdc-1 knockout cells in this study.  
It should be noted that one potential limitation of our studies is the use of cultured 
cells to study the function of glycocalyx components. Cultured cells are known to have 
limited formation of glycocalyx in comparison to the extended structure found in in vivo 
vessels141,142. Thus, while our findings support a functional role for sdc-1 they do not 
rigorously substantiate it in the presence of the full glycocalyx structure that is present in 
in vivo conditions. Additionally, while the lentiviral overexpression of sdc-1 is highly 
effective in expressing the protein in knockout cells it also has some limitations. Namely, 
having high levels of sdc-1 may disrupt the normal function of the protein and 
overwhelm the heparan sulfate synthetic enzymes that perform the post-translational 
modification of the protein. In addition, sdc-1 is a ligand for the viral entry of the HIV 
lentivirus. Thus, there may be effects on this system from the cell response to lentiviral 
transduction. These mechanisms may, in part, explain why there is a partial, but not 
complete, reduction of leukocyte adhesion by sdc-1 overexpression.  
 
4.6. CONCLUSIONS 
In summary, our study demonstrates that sdc-1 is a key element in endothelial 
mechanosensing and suggests an atheroprotective role for sdc-1 in flow-mediated 
endothelial phenotypic regulation. Our work supports that loss of sdc-1 from the 
endothelial surface leads to the adoption of a pro-inflammatory phenotype that is 
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dysregulated in response to the atheroprotective effects of flow. Many disease states 
increase the expression of enzymes that could induce the shedding and degradation of 
sdc-1 causing its loss from the endothelial surface135,143,144. Thus, therapies that preserve or 
enhance sdc-1 on the endothelial surface, either through increased expression or 
inhibition of shedding, may have potential in preventing the early stages of atherogenesis 
and enhancing the atheroprotective effects of shear stress. 
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Chapter 5: Role of Syndecan-1 In Vivo3 
 
5.1 INTRODUCTION 
 To effectively investigate the effects of shear stress in a truly physiological 
framework, in vivo studies are required. While in vitro studies allow us to isolate 
particular elements of a complex system to test their effects, the complex nonlinear 
dynamics between endothelial cells and smooth muscle cells, blood components, and 
extracellular matrices must be tested in animal models to see if the in vitro findings might 
be able to translate to actual therapeutics. Since we used our wild-type and syndecan-1 
knockout mice to isolate the cells for in vitro testing, we are able to use the same genetic 
systems to test in whole animals. By testing the effects of shear stress on our animal 
models we can examine some of these complex dynamics. 
 In our in vivo studies, we focused on three main areas of investigation. Firstly, we 
wanted to look at how regions of the vasculature that natively experience different levels 
of shear stress differ in their endothelial phenotype. The greater and lesser arches of the 
aorta have been shown to exhibit laminar and disturbed flow, respectively, and being next 
to each other in the same vessel are a very good target for examining differences that are 
most likely caused only by the shear stress itself. This works well for examining 
differences that chronically exist, but to examine short-term changes and differences that 
may arise from vessel occlusion we also conducted studies to look at differences in 
induced shear stress changes. Specifically, using a partial carotid ligation model we 
created disturbed flow along the left carotid artery and examined how that affected 
                                                
3 Some work contained in this chapter was previous published in the following journal article: Voyvodic, P. 
L., et al. Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated 
response to atheroprotective flow. Journal of Biological Chemistry 289 (14), 9547-9559, doi: 
10.1074/jbc.M113.541573 (2014). The individual contributions by the authors are as follows: Peter L 
Voyvodic- Principle author and conductor of the research; Daniel Min- Undergraduate research assistant to 
PL Voyvodic; Robert Liu- Undergraduate research assistant to PL Voyvodic; Evan Williams- 
Undergraduate research assistant to PL Voyvodic; Vipul Chitalia- No contribution to Chapter 5; Andrew K 
Dunn- Helped design laser speckle contrast imaging setup; Aaron B Baker- Supervisor to PL Voyvodic. 
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neointimal formation. Finally, we wanted to look at some broad changes in how 
syndecan-1 affects vessel structure and global inflammatory response. By looking at the 
aortic medial thickness and general response to transdermal inflammatory stimuli we 
showed that syndecan-1 knockout mice appear to have an elevated level of inflammation. 
5.2. MATERIALS AND METHODS 
5.2.1. Animal Experimentation 
All animal procedures were conducted in accordance with protocols approved by 
the University of Texas at Austin’s Institutional Animal Care and Use Committee. 
Syndecan-1 knockout (Sdc1-/-) mice were used as previous described145 and were a kind 
gift from Dr. Ram Sasisekharan (Massachusetts Institute of Technology). 
5.2.2. Gene Expression in Aorta Regions with Different Native Shear Stress. 
Wild-type and sdc-1 knockout mice were euthanized by CO2 inhalation and 
sections of the greater and lesser aortic arch and the descending aorta were excised, 
rinsed in saline, and frozen in liquid nitrogen. The tissue segments were lysed by bead 
beating (Qialyser; Qiagen) and messenger RNA was isolated using an RNAeasy kit 
(Qiagen). The relative mRNA copy numbers were quantified using real time PCR as 
described previously118,119.  Copy numbers were normalized to GAPDH gene expression. 
5.2.3. Histological Analysis of Mouse Aortas. 
 Mice were euthanized via CO2 inhalation and the chest cavity opened. The aorta 
was isolated from the surrounding connective tissue and a small incision was made in the 
descending aorta near the diaphragm. A small, approximately 8mm x 15mm piece of 
silicone membrane was placed under the aorta to separate it from the surrounding tissue. 
Using a 21G needle to puncture the left ventricle, the aorta was flushed with saline and 
then filled with optimal cutting temperature (OCT) compound. Liquid nitrogen-cooled 
isopentane was then poured onto the aorta to freeze it in situ, at which point it was 
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excised and frozen in liquid nitrogen. Later, the tissue was fixed for 48 hours in 10% 
formalin at 4°C with shaking and then stored in 70% ethanol at 4°C. Samples were 
paraffin embedded and sectioned along the coronal plane by the Histology and 
Immunohistochemistry Laboratory at The University of Texas Health Science Center at 
San Antonio and hematoxylin and eosin (H&E) staining was performed. 
Immunohistochemical staining with a Dako kit (Agilent) was performed with 1:250 
primary antibody dilution against VCAM-1 (Cell Signaling) according to the 
manufacturer’s directions.  
 Additionally, for the transverse sections of wild-type and sdc-1 knockout mice, 
aortae were flash frozen in liquid nitrogen-cooled isopentane and cryosectioned 
transversely along the descending aorta. Sections were then stained for a modified 
Verhoeff’s Van Giesen stain as previously described146. 
5.2.4. Partial Carotid Ligation Surgery. 
 In order to examine the effects of induced changes in shear stress in vivo, we 
elected to use the partial carotid ligation surgery as previous developed by Nam et al45. 
Briefly, the mice were anesthetized with 3% isoflurane and an ~1cm vertical incision was 
made on the underside of the neck above the left carotid artery (LCA). Once the LCA is 
exposed, two ligations are made on the downstream branches with 5-0 silk sutures: one 
occludes the external carotid artery (ECA) and occipital artery (OA) and the other 
occludes the internal carotid artery (ICA). This forces all downstream blood flow through 
the superior thyroid artery (STA) and creates a large region of disturbed flow upstream in 
the LCA. After the ligations are tightened, the incision is sutured closed and the mouse is 
given an injection of 2 mg/kg of carprofen and monitored. We confirmed the effects of 
the partial carotid ligation surgery by monitoring blood flow velocity in the ligated and 
control carotid arteries using pulsed wave Doppler with a Vevo 2100, high frequency 
rodent ultrasound system (VisualSonics).  
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5.2.5. Histological Analysis of Mouse Carotid Arteries. 
Thirty days after partial carotid ligation surgery, mice were euthanized via CO2 
inhalation and the control and ligated carotid arteries were frozen in liquid nitrogen-
cooled isopentane. Later, the tissue was fixed with for 48 hours in 10% formalin at 4°C 
with shaking and then stored in 70% ethanol at 4°C. Samples were cut in half and sent to 
the Histology and Immunohistochemistry Laboratory at The University of Texas Health 
Science Center at San Antonio where they were paraffin embedded and sectioned 
transversely at either 2 mm or 7 mm downstream of the aorta. Hematoxylin and eosin 
(H&E) staining was performed according to standard protocols.  
5.2.6. Measurement of Global Inflammatory Response using Laser Speckle Contrast 
Imaging. 
To examine the inflammatory response of WT and S1KO mice, we anesthetized 
the mice and applied 5% allyl isothiocyanate, a potent inflammatory/permeability 
stimulus, to the hind feet of the mice. We subsequently imaged the feet of the mice over 
time using a laser speckle imager. Laser speckle imaging allows the real time 
measurement of tissue perfusion with tens of microns spatial and millisecond temporal 
resolution147. Briefly, a diode laser (785nm, 50mW; Thor Labs) was shown upon the 
footpad of a mouse hindlimb. A Basler 1920 x 1080 monochrome CCD with a zoom lens 
(Zoom7000; Navitar) mounted on a microscope boom stand was placed vertically over 
the foot and used to record speckle images of blood perfusion. The raw speckle images 
were converted into speckle contrast images using the following relation: 
 
where ss is the standard deviation and is the mean intensity over a 7 x 7 pixel region 
of the image. The speckle contrast images were quantified by assigning values of 0, 1, 
and 2 to the red, green, and blue channels and multiplying by the area to integrate the 
total signal. Each time point was then normalized to the pre-oil measurement. 




5.2.7. Histological Analysis of Mouse Foot Pads. 
The feet of mice from the mustard oil laser speckle experiment were fixed in 4% 
paraformaldehyde and stored at 4°C. The foot pads were then removed and stored in 
PBS/20% sucrose for 48 hours at 4°C with shaking before freezing in liquid nitrogen 
cooled isopentane. The frozen foot pads were cryosectioned and stained as described 
previously119.  
5.2.8. Statistical Analysis. 
All results are shown as mean ± SEM. Comparisons were analyzed using a 




5.3.1. Lack of syndecan-1 causes elevated levels of E-selectin and VCAM-1 in 
atheroprone aorta regions. 
 In order to examine the effects of different levels of native shear stress on 
endothelial phenotype, we looked at the greater and lesser aortic arches. Previous 
experimental and computational data have shown that the greater arch experiences high 
levels of atheroprotective shear while the lesser arch experiences a disturbed, atheroprone 
shear profile148. To look at the gene expression differences present in these two 
environments, we lysed and performed real-time PCR on isolated sections of the greater 
and lesser arch from WT and S1KO mice. An excised ring from the descending aorta was 
used as a control (Figure 5.1). Although not statistically significant, the sdc-1 knockout 
mice exhibited higher levels of E-selectin and VCAM-1 expression in the lesser arch 
compared to the wild-type. 
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5.3.2. Syndecan-1 knockout mice have higher VCAM-1 expression in regions with 
atheroprotective flow. 
 We also looked at the differences in protein expression in the aortic regions of 
differing shear stress. Paraffin-embedded WT and S1KO aortae were coronally sectioned 
and stained for VCAM-1 using a Dako immunohistochemical staining kit (Figure 5.2). 




Figure 5.1. Lack of syndecan-1 causes elevated levels of E-selectin and VCAM-1 in 
atheroprone aorta regions. (A) Cartoon illustrating excised regions for gene expression 
analysis. (B) Pictures of aorta before, during, and after tissue removal. (C) S1KO mice 
appear to have higher gene expression levels of leukocyte-binding proteins E-selectin and 
VCAM-1.  
5.3.3. Partial carotid ligation induces increased neointimal formation in Sdc-1 
knockout mice. 
 To investigate the effects of a S1KO model in an induced disturbed flow 
environment, we used a partial ligation surgery technique previously developed by Nam 
et al45. To confirm the effects of the surgery and monitor the vessel remodeling, we used 
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showed that the ligated carotid artery had a dramatic reduction in flow that included 
reverse flow at the end of each stroke (Figure 5.3A and 5.3B). Thirty days post-surgery 
we euthanized the mice and sectioned and stained the control and ligated carotid arteries 
with hematoxylin and eosin (H&E) to examine neointimal formation (Figure 5.3C). We 
measured the intimal, medial, and adventitial cross-sectional areas and found that the 
S1KO mice had a significantly increased neointimal formation (Figure 5.3D). 
 
 
Figure 5.2. Syndecan-1 knockout mice have higher VCAM-1 expression in regions 
with atheroprotective flow. Immunohistochemical staining shows higher levels of 
VCAM-1 expression in the atheroprotective greater arch in syndecan-1 knockout mice.  
5.3.4  Syndecan-1 knockout mice exhibit  aortic medial thickening. 
 WT and S1KO mice aortas were cryosectioned and stained via a modified 
Verhoeff’s Van Giesen stain to examine aorta medial thickness. Measurements were 
made using Metamorph by determining the average distance between the innermost and 
outmost elastic lamina. We observed that the S1KO aortae had an increased medial 
thickness (Figure 5.4).  
5.3.5. Syndecan-1 knockout mice have increased global inflammatory response. 
To examine the global inflammatory state we examined the functional response of 
WT and S1KO mice to a vasodilatory/inflammatory stimulus. We applied mustard oil to 
WT S1KO 
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the feet of anesthetized mice and measured the increase in blood flow over time using 
laser speckle imaging. We found that S1KO mice had a greater increase in perfusion in 
response to the same level of treatment with mustard oil (Figure 5.5A and 5.5B). 
Histological analysis revealed qualitatively greater edema in the feet of S1KO mice in 
comparison to WT mice (Figure 5.5C). 
 
Figure 5.3. Partial carotid ligation surgery induces increased neointimal formation 
in syndecan-1 knockout mice. (A) Picture of ligation sites after left carotid artery 
bifurcation. (B) Ultrasound pulsed wave Doppler measurements confirmed post surgery 
that there was a dramatic reduction in flow with backflow in the ligated carotid. (C) H&E 
stains of control and ligated carotid artery sections thirty days after surgery. Scale bar = 
200 μm. (D) S1KO mice exhibit higher levels of neointimal formation from intimal areas 
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Figure 5.4. Syndecan-1 knockout mice exhibit increased aortic medial thickness. (A) 
WT and S1KO mouse aortae were sectioned and stained using a modified Verhoeff’s 
Van Giesen stain. Scale bar = 200 μm (Mag = 50 μm). (B) Syndecan-1 knockout mice 
had thicker medial layers relative to the wild-type mice (p<0.05).  
 
5.4 DISCUSSION 
 While we can learn a lot about the mechanisms of mechanotransduction using in 
vitro studies, the complex dynamics between cell types and environmental niches 




























order to investigate how syndecan-1 plays a role in endothelial mechanotransduction in 
vivo, we conducted animal studies using wild-type and syndecan-1 knockout mice. 
Having a mouse model in which our protein of interest is absent gives us a powerful 
toolset to study the effects of shear stress. We wanted to examine how the endothelium of 
syndecan-1 knockout mice might differ in both native and induced shear stress changes to 
see if our in vitro findings carry through to a larger order system. 
 
 
Figure 5.5. Inflammatory responsiveness is increased in sdc-1 knockout mice. (A) 
The foot pads of mice were treated with mustard oil (allyl isothiocyanate) and the 
response was measured by tracking tissue perfusion using laser speckle flow imaging. 
S1KO mice had an increased response to the mustard oil. (B) The S1KO mice showed an 
increase in relative blood perfusion relative to the WT mice. *p < 0.05 versus WT group 
at given time point. (C) Histological analysis of the foot pads of (WT) and S1KO mice 
after H&E staining. Scale bar = 400 μm (Mag = 150 μm). 
 Throughout the vasculature, the complex geometry that governs blood flow also 
leads to a complex range of wall shear stresses. In general, inside edges of high angle 
curvature and vessel expansions after bifurcations create regions of disturbed flow where 
development of atherosclerotic plaques is more common. We examined the aorta due to 
the differing shear stress levels present in close proximity to one another. These 






respective endothelia, specifically higher VCAM-1 levels in atheroprone regions149. To 
examine these changes using our syndecan-1 knockout model, we examined both the 
gene and protein expression in these regions. 
 Using real-time PCR, we examined gene expression in the greater and lesser 
arches of WT and S1KO mice as well as in the descending aorta as a control. While the 
results are not quite statistically significant, they do suggest that the lesser arch of the 
syndecan-1 knockout aorta exhibits higher mRNA levels for both E-selectin and VCAM-
1. The noise in the system is at least partially contributed to the method of the technique. 
When the tissue segments are excised and lysed, the endothelial cells only make up a 
fraction of the total cell number; most of the cells are smooth muscle cells. Thus some of 
the changes that might be clearer by looking only at endothelial cells are muted in our 
broad tissue lysis approach. 
 To examine the effects specifically on endothelial cells, we used histology and 
immunohistochemistry, which preserves the spatial geometry of the cells and can allow 
us to specifically examine the effects on the endothelium. By taking sections of aortae 
along the coronal plane, we were able to obtain sections that show the endothelium of 
both the greater and lesser arch of the aorta as well as the branches of the aortic 
birfurcations. We saw that similarly to our gene expression experiments, there was a 
higher expression of VCAM-1 in our S1KO model. Interestingly, while we didn’t see a 
change in gene expression in the greater arch in mRNA, there appears to be higher 
protein levels of VCAM-1 in the S1KO greater arch. This is most likely due to the 
muting of the endothelial-specific expression signal when we lyse the entire vascular 
segment. 
 Native shear stress differences allow us to examine the effects of chronic 
differences in varying areas of the vasculature. However, these mice are healthy and do 
not experience much of the vessel occlusion that is present in later stages of 
atherosclerosis. To examine how the endothelium responds to changes in shear stress 
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levels we utilized surgical techniques to induce changes in shear. Several methods have 
been used previously to create these changes. The carotid cuff model was first used by 
Cheng et al. and involves placing a perivascular cuff around the carotid artery and tying it 
off to constrict blood flow44. While this is very effective at altering flow profiles within 
the artery, the cuff itself can cause an inflammatory response that is difficult to 
distinguish from changes due to the shear stress alone. We opted to use the partial carotid 
ligation surgery first developed by Nam et al45. This surgery involves tying off three of 
the four downstream bifurcations of the left carotid artery, which limits blood flow to the 
smaller superior thyroid artery. Nam et al. showed both computationally and 
experimentally that this creates a region of disturbed flow with oscillatory backflow 
along the length of the carotid artery without necessitating an implantation on the carotid 
itself. Using ultrasound imaging to confirm the success of our surgery, we found that 
after thirty days the S1KO mice developed a more pronounced neointimal formation than 
the WT mice. While the neointimal formation was not as profound as Nam et al. found in 
the more canonically atherosclerosis prone ApoE -/- mouse model, it does suggest that 
syndecan-1 may play a significant role in vessel stenosis. 
 Finally, we wanted to see how S1KO mice may differ in their aortic thickness and 
general inflammatory response. We found that the S1KO mice had pronounced aortic 
medial thickening when compared to the WT mice. This likely changes the mechanical 
properties of the aorta and may make them more prone to the development of aortic 
aneurysms. To test the mice for their general inflammatory response, we applied a 5% 
allyl isothiocyanate solution to the hind paws of anesthetized mice. This transdermal 
application has been shown to activate TRPA1 ion channels and induce an inflammatory 
response150. Using a custom laser speckle contrast imaging set up in our laboratory, we 
measured the increase in blood flow as the mouse responded to the inflammatory 
stimulus and saw that the S1KO mice had a more robust response. Additionally, 
histology of the footpads after the stimulus appears to show increased levels of edema in 
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the S1KO mice. These results are consistent with our findings that show that syndecan-
1’s absence induces a chronic inflammatory state and its translation to the hind foot paw 
may mean that syndecan-1 plays a specific role in peripheral vascular disease as well. 
 
5.5 CONCLUSION 
 Determining the role of syndecan-1 in endothelial shear-mediated 
mechanotransduction necessitates using in vivo studies to validate in vitro findings. We 
showed that in native regions of different shear stress in the aorta an absence of 
syndecan-1 produces a pro-inflammatory environment, specifically through the 
upregulation of VCAM-1. Additionally, in response to an induced disturbed flow in the 
carotid artery via surgical techniques, S1KO mice exhibit a greater degree of neointimal 
formation. Finally, S1KO mice have thicker aortic medial layers and react more strongly 
to externally applied inflammatory stimuli. These findings help to validate the pro-
inflammatory state we observed in S1KO endothelial cells in vitro. It is possible that 
delivery of syndecan-1 via proteolipisomal vectors could help regulate the endothelial 
mechanotransduction response and be involved in novel areas of cardiovascular 
therapeutics.  
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Chapter 6: Conclusions 
The main objective of this thesis was to investigate the initial sensory mechanisms 
that endothelial cells use in shear-mediated mechanotransduction to drive their overall 
expression to a healthy or diseased phenotype. We hypothesized that, based on previous 
research, the heparan sulfate proteoglycan, syndecan-1, was a good candidate for 
initiating the mechanosensing signaling cascade. While a growing body of research has 
investigated how endothelial cells change in response to shear stress, the initial sensing 
mechanisms responsible for driving these changes remained unclear. Recently, the thick 
layer of glycans and proteoglycans known as the glycocalyx has become an increasingly 
popular target of interest due to its pronounced protrusion into the lumen and direct 
interaction with blood flow. Previous studies demonstrated that the endothelial shear 
response is impaired by enzymatic degradation of the glycosaminoglycans found in the 
glycocalyx48 and that levels of proteoglycan expression change in response to shear 
stress19. However, to date there had been no other comprehensive study of the 
involvement of specific proteoglycans in the mechanotransduction response. Thus we 
sought to investigate the role of syndecan-1 in this response. 
To the best of our knowledge, the results of this dissertation are the first 
comprehensive study examining the endothelial shear-mediated mechanotransduction 
response of a glycocalyx proteoglycan using a global knockout model with both in vitro 
and in vivo studies. In order to conduct these experiments, we wanted to first improve 
upon existing in vitro shear stress application technology to facilitate cell culture 
experiments. We constructed three different shear stress application systems (Chapter 3): 
(1) an optimized, multithroughput parallel-plate system that allowed for unprecedented 
shear stress experiments in parallel while minimizing media volume requirements, (2) a 
modification of our first system to better accommodate downstream applications such as 
Western blotting and conditioned media assays, and (3) a modular cone-and-plate system 
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that enables the application of a wide range of physiologically dynamic shear waveforms. 
Using endothelial cells harvested from wild-type and syndecan-1 knockout mouse 
models, we showed that endothelial cells lacking syndecan-1 have a reduced response to 
shear stress and exhibit a persistent pro-inflammatory phenotype (Chapter 4). To validate 
these findings physiologically, we looked at the differences in wild-type and syndecan-1 
knockout mice to both differing native and induced shear stress environments (Chapter 
5). Syndecan-1 knockout mice exhibited higher levels of leukocyte-binding protein 
VCAM-1 in regions of known disturbed shear stress. Additionally, they exhibited 
increased neointimal formation in response to induced disturbed flow using a partial 
carotid ligation surgery. These findings demonstrate the syndecan-1 clearly has a role in 
the endothelial mechanotransduction pathways and further investigation of these 
pathways may lead to new targets for clinical therapeutics. 
While we have uncovered many interesting findings regarding syndecan-1’s role 
in shear stress, there remain several future work options to continue these studies. To 
examine the mechanisms by which syndecan-1 transmits a signaling cascade we have 
created several genetic mutations. Specifically, we have created a genetic version of 
syndecan-1 in which the five serine residues for glycosaminoglycan attachment have 
been mutated into alanines. This produces a syndecan-1 core protein that does not have 
any GAG component. Additionally, we’ve designed a mutant that contains a stop codon 
after the transmembrane segment and thus lacks the cytoplasmic tail. Using a lentiviral 
vector system, we will reintroduce either wild-type syndecan-1 or one of our mutations 
into sdc-1 knockout endothelial cells and examine how these mutated versions change the 
signaling response. This will give us a more detailed mechanistic understanding of these 
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